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Introduction 5 
1. Introduction 
 
Adenocarcinoma of the prostate is one of the most frequently diagnosed 
carcinoma in males. It begins when normal semen-secreting prostate gland 
cells mutate into cancer cells. The region of the prostate gland where the 
adenocarcinomas are most common is the peripheral zone [1]. Over time, 
these cancer cells begin to multiply and spread to the surrounding prostate 
tissue (the stroma) forming a tumor. Eventually, the tumor may grow large 
enough to invade nearby organs such as the seminal vesicles or the rectum, 
or the tumor cells may develop the ability to enter in the bloodstream and 
lymphatic system. Prostate cancer (PC) is considered a malignant tumor 
because it is a mass of cells that can invade other parts of the body. Prostate 
cancer most commonly metastasizes to the bones and lymph nodes [2,3].  
 
1.1. Prostate cancer and bone metastasis 
 
At the early stages of cancer, surgical and hormonal therapies can be applied 
and be useful. After some point cancer cells form hormone-independent cells, 
which can also convert into highly invasive cell types. The tendency of the PC 
cells to metastasis originates from specific molecular mechanisms and 
interactions that together lead to local infiltration of tumor cells into the 
adjacent tissue, transendothelial migration of cancer cells into vessels known 
as intravasation, survival in the circulatory system, followed by endothelial 
attachment, extravasation and site-specific establishment of metastases at 
secondary sites [4–6]. Development of the PC into a metastatic state causes 
patients to end up with complications that may not be curable. In most of the 
cases, which involve the skeleton as a metastatic site for PC, events occur in 
a similar way, with lesions tending to appear first in the axial skeleton and 
subsequently in the appendicular skeleton [7]. Skeletal metastasis causes 
significant complications including bone pain, impaired mobility, pathological 
fracture and spinal cord compression [8]. 
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Figure 1: Formation of metastasis at the distant bone sites. Metastasis is characterized by 
proliferation at the primary site, neovascularization and intravasation into the circulation. In 
the circulation, circulating tumor cells (CTCs) interact with the host immune system, typically 
resulting in cancer cell destruction or apoptosis. Surviving cells arrest at secondary 
endothelial sites by a process of lectin binding consolidated by integrin-based stabilization of 
the epithelial–endothelial binding. The cells then undergo active transmigration and 
extravasate into the secondary site. Once the cells reach the bone marrow stroma, they may 
remain dormant for an undefined period or may proliferate and hence form a metastatic 
colony (based on [4]). 
 
1.1.1 Local invasion and migration 
 
Tumor growth depends on angiogenesis and lymphangiogenesis triggered by 
chemical signals from tumor cells in a phase of rapid growth. Without vascular 
support, tumors may become necrotic or even apoptotic [10]. Cancer cells 
also need to develop altered affinity for their extracellular matrix (ECM). The 
phenotypic change is initially mediated by alterations in the expression of cell-
surface molecules known as integrins, release of proteases that remodel the 
ECM and deposition of new ECM molecules. Various signal transduction 
pathways are activated resulting in regulation of gene expression, cytoskeletal 
organization, cell adhesion and cell survival. As a result, cancer cells become 
more invasive, migratory and are able to survive in different 
microenvironments [11]. 
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Local invasion is one of the fundamental early steps in metastasis formation, 
as without it tumor spread cannot occur. To develop invasive potential, the 
malignant cell must downregulate its cell–cell and cell–matrix adhesive 
characteristics, become motile and must acquire the ability to break down the 
ECM by using degradative enzymes [12]. Normally, the cells forming the 
epithelial sheets are strong enough and tightly bound to each other, to 
neighbouring cells or basement membranes by adherens junctions, tight 
junctions, desmosomes and hemi-desmosomes. These connection sites keep 
normal epithelial cells, as well as benign carcinomas inside the boundaries. 
However, as a tumor progresses, some of the carcinoma cells inside this 
tumor detach themselves from these limiting constraints and begin to move 
out on their own, first by dissolving underlying basement membranes and then 
invading adjacent stromal compartments. This acquired invasiveness seems 
to allow carcinoma cells to both intravasate and subsequently extravasate 
[13]. Within individual tumors, the populations of neoplastic cells are not 
homogeneous. Inside carcinomas, the subpopulations of cancer stem cells 
(CSCs) seem to be responsible from many of the biological traits of high 
grade malignancy [14]. Invasiveness, motility and self-renewal, which are 
principal traits for malignancy, may be the reflection of the CSC 
subpopulations.   
In early embryonic morphogenesis, cell-biological program called epithelial-to-
mesenchymal transition (EMT) enables cells of epithelial phenotype in the 
ectoderm to migrate, generate mesenchymal derivatives, invade and insert 
themselves between ectoderm and endoderm layers. This transdifferentiation 
program is driven by EMT-inducing transcription factors (EMT-TFs) [15].  
A variety of cell types are recruited to the surrounding stroma of advanced 
primary tumors. These recruited cells, incluiding fibroblasts, granulocytes, 
macrophages, mesenchymal stem cells, and lymphocytes create a “reactive” 
stroma, and form an inflammatory microenvironment that appears to result in 
the release of EMT-inducing signals. Expression of certain EMT-TFs are 
activated in carcinoma cells that govern EMT programs inside the cells [16]. 
Recent studies have reported that the EMT can induce non-CSCs to enter 
into a CSC like state [17]. Essentially, the set of traits that would allow 
epithelial cells to disseminate from primary tumors and seed metastases are 
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results of EMT. Thus, EMT is an attractive way to understand the 
mechanisms of dissemination. Moreover, the acquired resistance to apoptosis 
that is central to cells generated by an EMT is surely critical for the ability of 
carcinoma cells to survive the difficult journey from primary tumors to 
secondary metastatic sites [18].  
E-cadherin is a transmembrane glycoprotein and it is used normally for critical 
functions during embryogenesis and organogenesis through intercellular 
adhesion and signaling [19]. The cadherin–catenin complex is essential for 
cell-to-cell adhesion. The locus coding for E-cadherin is well characterized 
and considered to be a tumour-suppressor gene as loss of E-cadherin 
function enables cell detachment and induces an invasive phenotype [20]. 
Actually, down-regulation of E-Cadherin is a critical component in the general 
process of EMT. Decreased E-cadherin expression has been associated with 
increased tumor stage, and with bone metastasis in PC [21].  Cell polarity and 
cell-to-cell binding are lost during this transition of epithelial cancer 
advancement and metastasis. These cells transform to a mesenchymal 
phenotype, which gives them the capacity to invade the ECM and move to 
distant sites [5]. 
Once the malignant cell has reached the stroma, it must enter the vascular or 
lymphatic circulation by permeating through the endothelial barriers. Tumor 
cells that are identified in transit within the blood stream are referred to as 
circulating tumor cells (CTCs) [22]. Tumor cells arrest on endothelial surfaces 
within the circulatory system and subsequently undergo transendothelial 
migration; this is another key event in cancer metastasis (Fig. 1). After that 
point, the cell binds to the endothelium, extravasates and transmigrates 
through the endothelial layer, where it proliferates and/or coalesces with other 
metastasized cells to form a micro-metastasis [5].  Interactions of tumor cells 
with the endothelium involve multiple adhesive connections (docking and 
locking) at the molecular level [23]. The initial binding step begins with 
selectins, followed by stabilization through integrin binding [24]. The surface 
proteins integrin αL, integrin β2, intercellular adhesion molecule (ICAM-1) and 
platelet endothelial cell adhesion molecule (PECAM-1) have been also shown 
to take part in the binding process [25]. Once the PC cells reach the bone 
marrow, the survival ones there establish a tumor microenvironment and build 
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a reactive stroma by interacting with other cells in the bone marrow [26].  
 
1.1.2 Survival in the bone  
 
The metastasis formation in particular organs is favored, because it may be 
influenced by differences in the structures of capillaries in various tissues. For 
example, the sinusoid capillaries in the bone marrow are thin structures and 
are formed from single layers of endothelial cells without any supporting cell 
lining, to facilitate the normal in and out trafficking of hemapoetic cells [27]. 
Because of this feature of bone marrow vessels, they may also be an easy 
destination for carcinoma cells and favorable site for metastasis for certain 
types of cancers (e.g., prostate, breast and lung) [28]. 
Cellular invasion and migration depend on the dynamic interaction between 
cells and the ECM. For instance, during invasion, cells release proteases that 
degrade and redesign the ECM, promoting cell passage through the stroma 
and entrance into new tissue [29]. During migration, cells extend lamellipodia 
and filopodia that attach to the ECM, and simultaneously break existing ECM 
contacts at their trailing edge. This permits the cell to move itself forward [30]. 
Most cancer cells that successfully translocate from the primary tumor to a 
secondary site undergo apoptosis within 24 hours of extravasation [31]. 
Colonization is an extremely inefficient process, and most of the cancer cells 
are wasted when they localize to a potential metastatic site. 
Favorable colonization is assumed to involve the ability to gain mitogenic 
stimulation from growth factors and cytokines that are naturally accesible in 
the alien microenvironment [32]. Micrometastases are made out of actively 
multiplying cells. Active cell division is crucial for the generation of genetic and 
epigenetic changes that are needed to create oppurtunities for cancer cells to 
develop complex colonization programs. Once the resulting derivatives 
appear in these micrometastases, their novel phenotypes can be evaluated 
for an ability to confer selective benefit in the presence of very challenging 
microenvironments.  
The spreaded mesenchymal tumor cells must go through the reverse 
transition to EMT, namely Mesenchymal – Epithelial Transition (MET) [33]. At 
the site of metastasis, cancer cells reproduce the pathology of their 
Introduction 10 
corresponding primary tumors. The rate-limiting step in metastasis is the 
inititation of tumor growth at the secondary site. This suggests that cellular 
plasticity, the ability to undergo EMT and subsequently MET in the favorable 
microenvironments, is a crucial feature of a successful metastatic cell [34]. 
Numerous complex signaling systems are required for the induction of EMT 
and are also closely linked with MET. For instance, the FGFR2 gene encodes 
for FGFR2b and FGFR2c isoforms due to alternative splicing. FGF10 and 
FGF7 are the binding partners of FGFR2b and FGFR2b is the isoform of 
choice in epithelial cells, whereas FGFR2c is expressed in cells of 
mesenchymal origin and binds FGF2. During the progression process of 
prostate cancer, a class switch from FGFR2b to FGFR2c occurs and EMT 
accompanies this switch with increased potential for invasion and metastasis 
[35]. In a research conducted by Matsubara et al. [36], prostate cancer cells 
with decreased FGFR2b expression were transfected with FGFR2b 
expression construct and the proliferation and tumorigenicity of the prostate 
cancer cells were shown to be significantly suppressed, suggesting that EMT 
might be reversed. Epidermal growth factor receptor (EGFR) is a member of 
the receptor tyrosine kinase family and plays a major role in normal 
development. They are constantly overexpressed in malignant tumors and are 
thought to contribute to tumor progression. Yates et al. [37] reported that in 
vitro inhibition of autocrine EGFR signaling increased E-cadherin expression 
and cell-cell heterotypic adhesion. E-cadherin and catenins are also present 
in human prostate cancer metastases to liver, but without an activated EGFR, 
supporting the idea that the inverse relationship between E-cadherin 
expression and EGFR also exists in human tumors. This suggests that MET 
processes take place in the cancer cells [38].  
When the cells enter the bone, they begin to interact with their environment 
and adapt themselves to the new conditions. The balance between the 
activities of osteoblasts (bone-forming cells) and osteoclasts (bone-lysing 
cells) in general determines the phenotype of metastatic bone lesions, and 
both type of cells have been implicated in bone metastasis [3]. Bone 
metastases with a bone-forming (osteoblastic) phenotype are the result of 
stimulation of osteoblasts or inhibition of osteoclasts (or both) by the cancer 
cells, whereas metastases with a bone-lysing (osteolytic) phenotype reflect 
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inhibition of osteoblasts or stimulation of osteoclast function (or both) by the 
cancer cells. Metastases from PC, most of which are adenocarcinomas, 
nearly always form osteoblastic lesions in bone; by contrast, bone metastases 
from kidney, lung or breast cancers more often are osteolytic. However, 
metastases from the relatively uncommon neuroendocrine tumours of the 
prostate also produce osteolytic lesions [7]. On the other hand researchers 
also observed that both osteoblastic and osteoclastic activities could be seen 
in the development of bone metastasis. Bones are remodeled in a way that 
osteoblastic activity causes increased mineralized bone formation on the sites 
of previous osteoclastic resorption. This process also takes place in normal 
bone development in a balanced way but metastatic state causes an increase 
in bone production [3,39].  
PC cells have ability to alter bone environment by secreting factors that either 
directly affect osteoblast functions or influence bone formation indirectly, by 
modifying the bone matrix or microenvironment (Fig. 2). These factors take 
part normally in bone development and remodeling. For example, expression 
of several bone morphogenic proteins (BMP) has been detected in bone 
metastases from prostate carcinomas [40].  
Concerning PC metastasis in bone, ET-1 production is a major factor in 
osteoblast overstimulation. ET-1 stimulates mitogenesis in osteoblasts. 
Tumor-produced ET-1 stimulates new bone formation via ETA receptor on 
osteoblasts. Incorporating growth factors produced by the osteoblasts into this 
new bone also enrich the local microenvironment. ET-1 induces PC 
proliferation by enhancing the mitogenic effects of insulin-like growth factor 
(IGF) and epidermal growth factor (EGF) as well [41].  Although ET-1 is an 
important factor, it is not the only osteoblast stimulator in PC metastasis. 
PC cells produce many factors, including Wnts that are implicated in tumor-
induced osteoblastic activity. Wnts are cysteine-rich glycoproteins that 
mediate bone development in the embryo and promote bone production in the 
adult. Wnts have been shown to have autocrine tumor effects, such as 
enhancing proliferation and protecting against apoptosis [42]. Some of the 
factors that are involved in the up-regulation of Wnt pathway, have also 
osteoblast regulatory roles, for example; bone morphogenic protein (BMP), 
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transforming growth factor-β (TGF-β), IGF, vascular endothelial growth factor 
(VEGF) and platelet-derived growth factor (PDGF) [43–46].   
Increment in osteoblast activity is in charge of the quantifiable enlargement in 
bone volume in PC bone metastases as well as for the accelerated bone 
mineralization rate [47,48]. The bone generated by prostate tumor stimulation 
is formed as abnormal ‘woven’ bone, characteristic of the bone produced in 
high-turnover states. This is the reason, why 90 % of the patients with 
metastatic PC have sclerotic lesions [47,49]. 
 
 
Figure 2: Putative mechanism of PC cell involvement in the bone. 1) PC cells secrete 
osteoclastic factors, which induce osteoclasts to resorb mature lamellar bone. 2) As the bone 
matrix is destroyed, it releases growth factors (e.g. TGF-β), which stimulates PC cells to grow 
and gain an osteoblast-like phenotype. 3) PC cells secrete osteoblastic factors (e.g. BMP, 
ET-1), which activate osteoblasts to form new woven bone (based on [3]). 
 
Genetic alterations in PC cells alone are not enough to confer metastatic 
status without a supporting tumor microenvironment. Effective therapeutic 
targeting requires a more comprehension of the interactions between tumor 
and stroma [50]. Metastasis is a complex process, which involves the 
coordination of several signal-transduction pathways that allow cancer cells to 
adhere, proliferate, remodel their surrounding environment, to invade and 
migrate through new tissues, and to differentiate. Blocking the adhesive, 
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migratory and invasive capacity of tumor cells may be challenging but would 
be a useful way to treat the patients with malignant disease.  
1.2. Collagen type-I  
 
Collagen is an abundant structural protein in all animals. In humans, collagen 
comprises one third of the total protein, accounts for three-quarters of the dry 
weight of skin, and is the most widespread component of the extracellular 
matrix (ECM). In vertebrates, 46 distinct polypeptide chains form at least 28 
different types of collagens [51]. 
The extracellular matrix of bone is mainly composed of type I collagen (Col-I), 
which is involved in bone mineralization process. For example, the mineralites 
of bone are stored almost solely within the collagen fibrils [52,53].    
The defining feature of Col-I is an elegant structural motif in which three 
parallel left handed polypeptide strands staggered to form a right-handed 
triple helix. The crucial importance of Col-I as a scaffold for the body demands 
multiple essential features. These features include thermal stability, 
mechanical strength, and the ability to enroll in specific interactions with other 
biomolecules [51]. 
The most common motifs in the amino acid sequence of Col-I are glycine-
proline-X and glycine-X-hydroxyproline, where X is any amino acid other than 
glycine, proline or hydroxyproline. Col-I has a hierarchical structure (Fig. 3). 
First, a three-dimensional stranded structure is assembled, with the amino 
acids glycine and proline as its principal components. This is not yet collagen 
but its precursor, procollagen. Procollagen is then modified by the addition of 
hydroxyl groups to the amino acids proline and lysine. This step is important 
for later glycosylation and the formation of the triple helix structure of Col-I. In 
addition N- and C- terminal ends are cleaved to form tropocollagen. Hydrogen 
bonds that form within the triple helix provides mainly its structural strength 
and stability. Individual tropocollagen monomers self-assemble into 
macromolecular fibers that are essential components of tissues and bones. 
Col-I is a well-packed molecule; the rigid triple helical structure is responsible 
for the characteristic tensile strength. Col-I forms distinctive banded fibrils. 
These fibrils have a periodicity of 67 nm and a diameter of 50-200 nm. The 
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molecules in fibrils of Col-I are packed in a hexagonal array [54]. In bone 
collagen is synthesized intracellularly in osteoblasts as large precursor, called 
preprocollagen. It is then secreted into the ECM. After enzymatic modification, 
the mature Col-I monomers aggregate and become cross-linked to form Col-I 
fibrils.  
PC cells can effectively attach and proliferate on Col-I [55]. Furthermore PC 
cells, which possess Col-I binding affinity, develop a significant number of 
bone tumors in contrast to cancer cells which do not attach to Col-I [56]. The 
PC cell line PC3 (bone metastatic cell) can spread and grow efficiently better 
on Col-I surfaces than on fibronectin surface [57]. The same integrins are also 
used by skin fibroblasts in the mechanism of modifying their Col-I containing 
ECM [58]. During invasion of bone tissue, prostate cancer cells need to 
establish connections to ECM proteins and grow on them. In addition, PC 
cells also need to degrade these ECM proteins to migrate through the bone 
tissue.  In the research conducted by Nabha et al. [59], it is found that the 
combination of human prostate cancer PC3 and BMS (bone marrow stromal) 
cells stimulates the invasive ability of cancer cells through Col-I. The use of 
inhibitors for each of the major protease families indicated that matrix 
metalloproteinase-12 (MMP-12) was responsible for the BMS-induced 
invasion of PC cells. Downregulation of MMP-12 expression in PC3 cells by 
siRNA inhibited the enhanced invasion induced by PC3/BMS cell interaction. 
Hence, it was concluded that BMS cells induce MMP-12 expression in 
prostate cancer cells, which results in invasive cells capable of degradation of 
Col-I [59]. 
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Figure 3: Biosynthesis of Col-I. Procollagen α-chains are synthesized. Propeptides 
are associated to form trimers. N- and C-terminal propeptides are removed and 
trimers assemble into fibrils that are covalently crosslinked. The 67 nm staggering of 
the trimers gives the fibrils a banded appearance (Based on [60]). 
 
1.3. Mesenchymal stem cells and their role in prostate cancer 
metastasis 
 
Mesenchymal stem cells (MSCs) have the capacity of differentiating into a 
variety of mesodermal lineages, including fibroblasts, chondrocytes, 
osteoblasts, and adipocytes under proper culture conditions. They are plastic 
adherent cells that can be isolated from bone marrow, as well as some other 
tissues like adipose tissue, skeletal muscle, dermis etc [61]. Homing of adult 
bone marrow-derived MSCs to the sites of tumor growth is a well known 
phenomena [62]. In a recent study, researchers showed that PC cells can 
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induce MSCs to differentiate into osteoblasts [63]. Available data in this area 
of research suggest that conditioned medium from metastatic PC cell line 
favors commitment of MSCs toward osteoblasts, while a nonmetastatic PC 
cell line fails to induce osteoblast differentiation in the same culture conditions 
[63]. In agreement with this observation, it has been shown that intratibially 
injected MSCs stimulate new bone formation only when coinjected with the 
PC cell line PC3 [64].  
Tumor cells are able to affect normal bone turnover by altering the bone 
marrow microenvironment, which has a reciprocal effect in promoting tumor 
growth. In the normal adult skeleton, bone is constantly being replaced in an 
interactive process controlled by osteoclasts, which are monocytic in origin 
and resorb existing bone [65]. This normal bone turnover may be disrupted by 
tumor cells at a number of levels. Uncoupling of normal bone turnover in 
favour of osteoclast activity induces osteolytic disease, typical of multiple 
myeloma and breast cancer-induced metastatic bone disease, whereas 
increased osteoblast activity induces osteosclerotic disease, characteristic of 
prostate cancer [66]. Tumor cells may directly induce osteolytic tumors in 
bone by activation or recruitment of osteoclasts via RANKL expression, a 
model proposed in multiple myeloma. Alternatively, tumour cells may alter 
osteoblast activation, either increasing osteoblast activity, resulting in 
osteosclerotic disease, or inhibiting osteoblast activation, resulting in 
osteolytic disease [65]. 
It has been suggested that the interaction between prostate cancer cells and 
another cell type, namely bone marrow stromal cells (BMSCs) is also critical 
for survival and proliferation of metastatic cancer cells in the bone 
microenvironment. BMSC-derived factors may be important for initial 
colonization and survival of prostate cancer cells in bone. Study using the 
osteoprotegerin, which is a factor produced by BMSCs and have inhibitory 
effect on TRAIL-induced apoptosis, have demonstrated that BMSCs protect 
PC cells from apoptosis [67]. Moreover, physical contact of metastatic PC cell 
with the BMSCs causes change in the expression of several genes. They 
include genes that function as growth factors, growth factor receptors, ECM 
proteins, cell adhesion molecules, proteases, and signal transduction 
molecules. Some of the genes that were regulated only by the physical 
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contact include collagen III α1, collagen IV α2, integrin α1 and α2, MMP-2 and 
-9, osteopontin, raf-1, biglycan and uPA. They differed from genes regulated 
by soluble factors, implying that a separate mechanism is activated by 
physical contact [68]. 
 
1.4. Integrins 
 
Integrins are a diverse family of heterodimeric transmembrane receptors that 
bind different ECM molecules (Fig. 4). The family consists of at least 25 
distinct pairings of 18 α-subunits and 8 β-subunits, with each pairing being 
specific for a unique set of ECM ligands. Extracellular domains of the integrins 
are formed by an elongated trunk and a globular ligand-binding head region. 
There are also short cytoplasmic tails connected to the actin cytoskeleton. 
Integrins can bind different ECM such as collagens, laminins and fibronectin. 
Depend on which ECM protein they bind, integrins can be divided into 
different subfamilies. Common short RGD peptide domains are present on 
fibronectin, vitronectin and fibrinogen, while laminin and collagens possess 
different binding domains. Specifically, six-residue GFOGER sequence was 
found to be the recognition site on Col-I triple helices for α2β1 integrin [69].  
Moreover, integrins expressed on the hematopoietic cells bind to counter 
receptors such as VCAM-1 or ICAM-1 on other cells [70].  
Integrins are enzymatically inactive receptors, which connect to intracellular 
molecules that can trigger signal transduction. Integrin activation results from 
the ability to assume various affinity states that can be regulated 
bidirectionally. “Inside-out signaling” refers to the intracellular events involving 
the cytoplasmic domains of α and β integrin subunits, which are coupled to 
extracellular conformational changes induced by extracellular factors. 
Integrins may increase signals generated by growth factor receptors by 
bringing kinases and substrates in close proximity [71]. Thus, integrins can 
move from an inactive state, in which they do not bind ligands, to an active 
state, in which they behave as high affinity receptors. Integrin activation is 
mainly regulated by talin, a large major actin-binding protein that associate to 
the cytoplasmic domain of β subunits. Talin binding to integrins disrupts an 
intracellular salt bridge between the α and the β subunit, leading to increased 
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integrin affinity, which strengthens the interaction with the ECM. In addition, 
the kindlin family of proteins synergises with talin in integrin activation, 
behaving as an essential co-activator of integrin signaling [72]. 
The term “outside-in signaling” refers to the activation of integrins upon ECM 
binding and transmission of the signals inside the cells. This is needed for 
polymerization of actin cytoskeleton during cell adhesion and regulation of cell 
migration, proliferation, survival and differentiation [73]. In focal adhesions, 
ECM binding leads to formation of clustered integrins in the plane of the cell 
membrane and these are connected to the actin cytoskeleton. Integrin 
associated structural cytoplasmic proteins such as talin, kindlin, vinculin and 
α-actinin are connected to F-actin at these focal adhesion sites, thus 
mobilizing actin filaments to integrin clusters [74].  Moreover, protein-protein 
interactions held by these integrin-associated molecules lead to multi-
functional scaffolding, which brings kinases, phophatases and their substrates 
together, hence regulating the dynamics of integrin-cytoskeleton joints [75]. 
The integrin clusters come in various forms, for example, focal adhesions, 
focal complexes, fibrillar adhesions, or podosomes, which are defined 
according to their size, shape, subcellular localization, molecular constituents, 
and organization [76]. The differences in size and composition of adhesion 
sites presumably reflect variances in the link to the cytoskeleton and integrin 
downstream signaling [77].  
Induction of cytosolic kinases, stimulation of the phosphainositides 
metabolism, activation of Ras/MAPK and PKC pathways and regulation of 
Rho GTPases could be regarded as integrin-mediated signaling events 
[78,79]. Signals from integrins, growth factor receptors or cytokines are well 
coordinated in a manner that the degree and duration of each signal differ 
depending on whether the growth factor receptors or the integrins are 
occupied by the ligand [70]. Integrin stimulation primarily results in tyrosine 
phosphorylation of proteins and this is a preferential way to transduce signals 
throughout the cell. For instance, the src family kinases (SFKs), focal 
adhesion kinase (Fak) and the adaptor molecule p130Cas are counted among 
the kinases that are activated and tyrosine phosphorylated upon ECM 
binding. In addition, these proteins play a distinctive role in integrin signaling 
[80,81]. 
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Figure 4: Schematic representation of a cell–matrix adhesion in which integrins connect the 
ECM to the actin cytoskeleton [based on 45]. 
 
Integrin expression varies between tumors and overexpression of some 
integrins have been associated with increased invasion [83–85]. In addition to 
change in protease activity, invasive cells also undergo dramatic alterations in 
levels of integrin expression and integrin affinity for ECM substrates. 
Numerous studies have documented marked differences in surface 
expression and distribution of integrins in malignant tumors compared with 
pre-neoplastic tumors of the same type [86]. For example, the integrin αvβ3 is 
strongly expressed at the invasive front of malignant melanoma cells and 
angiogenic blood vessels [87], but weakly expressed on pre-neoplastic 
melanomas and quiescent blood vessels. Furthermore, inducing expression of 
the αv [88] or β3 [89] integrin subunit in a melanoma cell line increases 
metastatic potential. Similarly, the laminin-binding integrin, α6β4, is not 
expressed in normal thyroid cells, but induction of its expression correlates 
with the progression to invasive thyroid carcinoma [90]. 
PC cells preferentially adhere to bone marrow endothelium cells when 
compared to other endothelium tissue with the help of β1 integrins [91]. The 
ligand/receptor interactions are the elements, which are mostly responsible for 
the mechanical properties of cell adhesive attachments. However, formation, 
strength, and survival of a cell adhesive attachment also depend on how 
cytoskeleton-anchored molecular connections below the membrane, respond 
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to force [77].  
 
1.5. Cell adhesion and single cell force spectroscopy  
 
Cell connections involve multiple ligands and cell adhesion molecules 
(CAMs). Cell adhesion is commonly defined as the binding of a cell to a 
substrate, which can be another cell, a surface or an organic matrix. One way 
to study biophysical aspects of cell adhesion is to apply single cell force 
spectroscopy (SCFC). The method of SCFS is the combination of atomic 
force microscopy (AFM) and optical microscopy. Optical microscopy is used 
to position the cells to assess cellular interactions at a given location on a 
functionalized surface, tissue or on another cell [92]. An AFM that is fitted with 
a fluid chamber allows measurements to be made in aqueous environments 
under controlled temperatures. Suspended cells are added to the fluid 
chamber and allowed to settle. Thereafter, a single cell is captured by gently 
pressing a functionalized AFM cantilever onto it [93]. This converts the living 
cell into a probe (Fig. 5A), which is brought into contact with functionalized 
surfaces or other cells at a set force and for a specific adhesion time. 
Subsequently, the cantilever is withdrawn at a constant speed, detaching the 
cell from its binding place. During this separation process, the cantilever 
deflection, which is proportional to the vertical force that exists between the 
cell and substrate, is recorded in a force-distance curve (Fig. 5B). This curve 
provides the biomechanical signature of the cell adhesion. Analyzing this 
curve may be challenging because adhesion signals, which are observed on 
this curve, could be specific adhesions or unspecific adhesions, which can 
occur at the same time. 
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Figure 5: Force spectroscopic measurement of the interaction between a cell attached on 
AFM cantilever and a cell immobilized on given surface. (A) Cell capture on Poly-D-Lysine 
(PDL) functionalized AFM cantilever (B) The attached cell on the AFM cantilever approaches 
the immobilized cell on specific surface, make a contact for a defined period of time and then 
retracts to a certain level where the two cells are completely separated. (C) De-adhesion 
steps can be read on the recorded force-distance curves. 
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2. Aim and goals of the thesis 
 
Prostate cancer (PC) is a malignant tumor, which commonly metastasizes into 
bone tissue. However, the exact mechanisms of how PC cells select this 
tissue as a metastatic site are still unknown and therefore, it is needed to 
investigate them in detail. Bone is a complex environment with several 
important cellular and matrix components building up the tissue. Collagen 
type-I (Col-I) is the most abundant cell matrix protein found in the bone 
environment and it has been already shown that an interaction of metastatic 
cells with this protein network is crucially important. On the other hand, 
mesenchymal stem cells (MSCs) residing in the bone marrow are precursors 
of the bone forming cells osteoblasts. Moreover, these MSCs have ability to 
secrete Col-I protein to make up their own extracellular matrix [94]. PC cells 
have several effects on these stem cells to form tumor microenvironment [68]. 
To investigate the mechanism of how PC cells invade bone marrow, several 
important questions should be addressed. Firstly, we should know whether 
these cells interact with the MSCs in the bone marrow; secondly, how strong 
they can adhere to Col-I and MSCs; and thirdly, what kind of forces are 
generated while these interactions are going on.  
Thus, the main aims of this study were to find out the biophysical 
characteristics of the interactions of PC cells with bone marrow-derived MSCs 
and the ECM protein Col-I and to identify the responsible cell adhesion 
molecules. 
We have defined the following goals to reach the above aims, which are: 
1. Comparison of two different prostate cancer cell lines, which are 
namely PC3 (derived from bone marrow metastasis) and LNCaP 
(derived from lymph node metastasis) in terms of their abilities to 
adhere on bone marrow-derived components.  
2. Estimating the affinity of these prostate cancer cells, during co-
culturing, towards MSCs in terms of adhesion, spreading and 
proliferation. 
3. Investigation of the involvement of the cell adhesion molecules 
(CAMs), specifically β1 integrins. Those may have important roles in 
the binding process between prostate cancer cells and Col-I or MSCs.  
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3.1. Analyzing integrin expression profile in the prostate cancer cell 
lines. 
3.2. Investigation of single molecule forces generated by CAMs using 
single cell force spectroscopy. 
4. Determination of the changes in the adhesion forces after blocking β1 
integrins and degradation of the Col-I.  
5. Detection of the participation of actin cytoskeleton in the adhesion of 
PC cells by inhibiting F-actin via Latrunculin-A treatment. 
6. Evaluation of the force spectroscopy data to decipher the anchorage of 
cell membrane receptors and their connection to the cytoskeleton.  
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3. Materials and methods 
3.1. General cell culture conditions  
 
PC3 and LNCaP cells were obtained from ATCC (Wesel, Germany). PC3 
cells were maintained in RPMI-1640 cell culture media (PAA, Cölbe, 
Germany) and 10% FBS (Sigma-Aldrich, Munich, Germany). The SCP1 cell 
line is an immortalized human MSC line fully described in Böcker et al [95]. 
LNCaP and SCP1 cells were cultured in Alpha-MEM GlutaMAX culture media 
(Life Technologies, Karlsruhe, Germany) supplemented with 10% FBS. 
During routine cell culture, the three cell types were grown up to 80% 
confluence in T-25 or T-75 culture flasks and maintained at 37°C in humidified 
5% CO2. The culture medium was changed three times per week and for cell 
passaging, cells were detached by treatment with 1x trypsin/EDTA solution 
(PAA). 
 
Figure 6: Phase contrast images of the cells grown in culture plates. PC cell lines 
PC3 and LNCaP are shown in (A) and (B) respectively. And MSC cell line SCP1 is 
shown in (C). Bars = 100μm  
 
3.1.1.   Cell passaging and counting 
 
Cell passaging was performed by washing the cell monolayer with PBS (PAA) 
and trypsinizing it with 1x Trypsin/EDTA (PAA) at 37 °C and 5 % CO2 for 5 
min. Detached cells were suspended in culture medium. A 10 μl of the cell 
suspension was used for cell counting. Cells were counted microscopically in 
a Neubauer chamber (brand, Grafrath, Germany). The total number of cells 
was determined by the following formula:  
cells/ml = cell number (counted in chamber A+B+C+D)   x 104 
                                              4         
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3.1.2. Cryopreservation 
 
A freezing medium was prepared prior cryopreservation. Freezing medium 
contained 70 % normal culture medium, 20 % FBS and 10 % dimethylsulfoxid 
(DMSO) (Merck, Darmstadt, Germany). After trypsinization and counting, cells 
were pelleted by centrifugation at 500 g for 5 min. The supernatant was 
completely aspirated and the cell pellet was resuspended in pre-cooled at 4 
°C freezing medium. Afterwards, the cell suspension was alliquoted in cryovils 
which were then stored -80 °C or in liquid nitrogen. 
 
3.1.3.  Cell culture prior capture of cells for force spectroscopy 
 
Cells (LNCaP or PC3) grown to 80% confluency were incubated in 
trypsin/EDTA solution (0.02%) for 5 min to 10 min until released from the 
substrate after washing with PBS lacking calcium and magnesium. This 
procedure should remove any matrix proteins possibly covering the cell 
surfaces without affecting the integrin receptors [96,97]. Then the cells were 
transferred with additional MEM-Alpha medium into a centrifuge tube. The 
cells were then spun down (1000 rpm, 3 min) before resuspending the pellet 
with fresh MEM-Alpha medium. The cells were left in an incubator at 37uC for 
15 min., in order to adapt them to the measurement temperature of 37uC in 
the AFM. Either PC3 or LNCaP cells (approx. 2 ml containing 100 to 300 
cells) were then gently injected onto the non-adhesive BSA-coated cover slip 
in order to subsequently capture one of them with the adhesive PDL-coated 
cantilever: The adhesive cantilever was positioned over one of the obviously 
healthy cells (medium size, round shaped at normal contrast, no blebs, no 
other abnormal indications in shape) on the BSA-coated cover slip, and 
lowered in a stepwise manner until it was close to the surface of this cell. 
Then, the cantilever was gently in held contact with the cell for a few seconds 
before the cantilever-bound cell was lifted vertically by approximately 100 mm 
[92]. The cell was allowed to establish firm adhesion on the cantilever for a 
couple of minutes. Some cells (approx. 10%) refused to adhere firmly to the 
lever rather hanging loosely as determined by gently shaking the microscope 
and watching the cell move with the induced agitation. In this case the cell 
Materials and methods 26 
was washed off the cantilever by lifting it out of the liquid and back again in 
order to capture a new cell. In the case of firm adhesion, the cell was used for 
adhesion experiments and monitored by the experimenter via the light 
microscope image during the entire period of measurements. 
 
3.1.4. Application of integrin blocking antibody 
 
After detachment of PC3 cells, the released cells were collected and washed 
with PBS (lacking calcium and magnesium). Prior to force spectroscopy and 
cell adhesion assay measurements, PC3 cells were suspended with fresh 
serum-free Alpha-MEM medium (Life Technologies) supplemented with 15 
mM Hepes (Sigma-Aldrich). Integrin β1 blocking antibody (Acris antibodies, 
San Diego, USA) in a concentration of 4.8 μg/ml was added into 0.5 ml cell 
suspension containing 2x105 cells and incubated for 30 minutes at 37°C. 
 
3.1.5.   Latrunculin-A treatment and fluorescent staining of actin 
cytoskeleton 
 
3 x104 PC3 cells were plated on two Col-I coated (100 μg/ml) glass slides. 
Cells were incubated overnight at 37 °C. One of the slides were treated with 
0.2 μM latrunculin-A (Sigma-Aldrich) diluted in culture medium containing 
0.2% FBS for 20 min at 37°C. After cells were washed with PBS, they were 
fixed %4 Paraformaldehyde/PBS for 15 min at room temperature. After 
fixation PC3 cells were used for staining of the actin cytoskeleton. Cells were 
rehydrated in PBS (3x5 min) and permeabilized with %0.2 Triton X-100 in 
PBS (Sigma-Aldrich) for 2 min. After applying Image-iT FX enhancer 
(Molecular Probes, Invitrogen) for 30 min, the actin filaments were stained 
woth dye Alexa Flour 546 labelled phalloidin (Invitrogen). Phalloidin was 
diluted 1:50 in 1% BSA/PBS and it was applied on cells in darkness for 20 
min. Finally, slides were rinsed in PBS (3x5 min) and mounted with anti-fading 
medium (6 g glycerol, 2.4 g Mowiol, 12 ml 0.2 M Tris HCl pH 8.5, 0.024 g 
DABCO and 6 ml dH2O. Fluorescent images were taken with the AxioCam 
MRm camera on Axiowert S 100 inverted microscope (Carl Zeiss) [98]. 
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3.2. Time-lapse microscopy and quantification of cell adhesion 
 
SCP1 cells (106 cells) were grown in 6-well dishes to full confluence. PC3 and 
LNCaP cells were labelled with the 10 mM green fluorescent CFDA dye 
(carboxyfluorescein diacetate, acetoxymethyl ester, Invitrogen) and then 
plated on the formed SCP1 monolayers (5 x 105 cancer cells/well). Directly 
after, microscopy images were collected with 25 minutes intervals for at least 
12 hours. Microscope stage was moving automatically to place the plates on 
the objective. Because of plate shake off effect non-adherent cells were kept 
out of focus and excluded in the imaging. During time-lapse the cells were 
kept in a bio-chamber, providing stable 37 °C and 5% humidified CO2 
atmosphere (Pecon, Erbach, Germany), mounted on an inverted optical 
microscope (Axiovert 100, Carl Zeiss Hallbergmoos, Germany). The images 
were taken with an AxioCam MRm CCD camera (Carl Zeiss) and by using 
manually the cell counter tool of Image J version1.40 software (National 
Institute of Health, USA) the number of adherent cells was estimated and 
shown as percentage to the initial cell input at 4 and 12 hours.  
 
3.3. Cell proliferation analysis 
 
SCP1 monolayers were formed as described above and 2 x 105 PC3 and 
LNCaP cells were added and left to expand onto SPC1 cells for a period of 8 
days. In addition, several culture wells were retained only with SCP1 cells 
(SCP1mono) in order to be used as controls for the quantification analysis. The 
co-cultures (PC3+SCP1, LNCaP+SCP1) were monitored microscopically and 
photographed with the AxioCam MRm camera (Zeiss). At day 1, 5 and 8 the 
cocultures were trypsinized and by using Neubauer cell counting chamber, 
the total cell number was estimated. The proliferation of PC3 and LNCaP cells 
on SCP1 monolayer (PC3on mono, LNCaPon mono) was calculated as follows: 
 
PC3on mono = PC3+SCP1 – SCP1mono 
LNCaPon mono = LNCaP+SCP1 – SCP1mono 
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3.4. Cell shape analysis 
 
Cell shape analysis PC3 and LNCaP cells (4 x104 cells/slide) were grown on 
Col-I (10 μg/ml protein) glass slides for 48 h. Then, the cells were fixed with 
4% PFA for 20 min at room temperature and maintained in PBS during the 
AFM scanning. From the AFM image data, using JPK Image Processing 
3.1.1.5 software (JPK Instruments), the following three parameters were 
estimated: h – height, A – area and V – volume. Using these parameters, the 
flatness shape factor f =  was calculated [23]. 
 
3.5. Optical density adhesion assay on 96-well plates 
 
Cell adhesion assays were performed according to Docheva et al [99]. Prior to 
the adhesion assays, 96-well plates were coated with 10 μg/ml Col-I at 4°C 
overnight and then blocked with 5% skim milk powder (Merck, Darmstadt, 
Germany) in PBS for 1 hour at 37°C. The wells were washed with PBS and a 
fraction of these wells was treated for 1 hour at 37°C with 200 μg/ml 
collagenase type-2 (in PBS 7,4 PH). PC3 cells (3x105) were plated and 
incubated for three distinct time periods at 37°C in humidified 5% CO2. Non-
adherent cells were removed by washing with PBS. The adherent cells were 
lysed and stained overnight at 37°C with a substrate buffer consisting of 7.5 
mM NPAG, 0.1 M sodium citrate, pH5.0 and 0.5% Triton X-100. Prior to the 
measurements, a stopping buffer (50mM glycine, pH10.4 and 5mM EDTA) 
was added to the wells and then the optical density was measured at 405 nm 
on a micro-titre-plate reader (Multiscan FC, Thermo Fisher scientific, 
Waltham, USA). The amount of adherent cells was finally calculated as a 
percentage of the absorption of 3x105cells, which were directly lysed with the 
substrate buffer. 
 
3.6. Immunofluorescent staining of collagen type-I 
 
Prior to protein coating, glass slides were cleaned with 70% ethanol and then 
autoclaved. In order to verify the collagen type I (Col-I) -coating of the glass 

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slides and the Col-I expression on SCP1, slides and SCP1 monolayers were 
prepared as follows. SCP1 cells were grown on glass slides for two days in 
order to form confluent cell monolayers, while Col-I - coated glass slides were 
prepared by adding 1mg/ml Col-I solution at 4°C overnight. Next, SCP1 
monolayers and the Col-I-coated slides were fixed with pure acetone for 20 
min at -20°C, rinsed with PBS. Image-iT FX Signal Enhancer (an Invitrogen 
product for background reduction and signal intensification of Alexa Flour 
secondary antibodies) was applied for 30 min and blocked with 10% BSA for 
1 hour. The primary mouse monoclonal anti-collagen-I antibody (Sigma) was 
applied overnight at 4°C. This step was followed by incubation with the 
secondary anti-mouse antibody conjugated to Alexa Flour 488 for 1 hour and 
the nuclear stain DAPI for 5 minutes. In parallel, negative controls were 
carried out by omitting the primary antibody. Photomicrographs were taken 
with an Axiocam MRm camera on an Axioskope 2 microscope (Carl Zeiss) 
using 40x objective. Additional SCP1 monolayer slides and Col-I coated slides 
were prepared to make analysis using confocal microscopy. 
 
3.7. Evaluation of integrin expressions with RT-PCR 
3.7.1.   Semi-quantitative PCR 
 
The semi-quantitative PCR was performed as described in Popov et al, 2011 
[100]. Briefly, total RNA was extracted from PC3 and LNCaP cells with 
RNeasy Mini Kit (Qiagen, Hilden, Germany) and 1 µg RNA was used for 
cDNA synthesis with AMV First-Strand cDNA Synthesis Kit (Invitrogen). 1:10 
diluted cDNA was used for PCRs. PCR for integrin α1, α2, β1 and GAPDH 
(used for normalizing the cDNA input) was performed with Taq DNA 
Polymerase (Invitrogen) in a MGResearch instrument (BioRad, Munich, 
Germany). Primer sequences and PCR conditions are available on table 1 
[100]. All PCR results have been reproduced three times independently. 
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Table 1: Primer sequences for RT quantitative and semi-quantitative PCRs. Abbreviations: 
F– forward; R – reverse; bp – base pairs (taken from Popov et al, 2011 [100]) 
 
3.7.2.   Quantitative-PCR 
 
The quantitative RT-PCR was performed as described in Popov et al [100]. 
Briefly, total RNA was extracted from PC3 and LNCaP cells with RNeasy Mini 
Kit (Qiagen, Hilden, Germany). For cDNA synthesis, 1 μg total RNA and AMV 
First-Strand cDNA Synthesis Kit (Life technologies) were used. LightCycler 
Fast Start DNA Master SYBR Green kit (Roche, Munich, Germany) and 
primer kits for α1, α2, α11, β1 and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) (all Search-LC, Heidelberg, Germany) were 
applied. The PCR was performed in LightCycler 1.5 instrument (Roche) 
equipped with LightCycler 3.5.3 software. Crossing points for each sample 
were determined by the second derivative maximum method and relative 
Primer pairs Product 
size 
(bp) 
Annealing 
temperature 
(°C) 
Integrin genes   
α1     
F: 5’-ACATCAGCCAAGTCAATGTTTCG-3’ 
R: 5’-AGCATTAACAGCAACAATCCGG-3’ 
241 51 
α2 
F: 5’-GCTGCTGTGCATTAGATATTAG-3’ 
R: 5’-CTGTAACTTCTGGTGAAATCCT-3’ 
217 48 
α11 
F: 5’-TGGGCGCACCCATGTACTTC-3’ 
R: 5’-ATGGCTCCTGCGTGGTTGTC-3’ 
223 55 
β1  
F:5’-ATGAATGAAATGAGGAGGATTACTTCG-3’ 
R: 5’-AAAACACCAGCAGCCGTGTAAC-3’ 
322 52 
House-keeping gene   
GAPDH 
F: 5’-CAACTACATGGTTTACATGTTC-3’ 
R: 5’-GCCGTGGCTCCACGAC-3’ 
181 50 
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quantification was performed using the comparative ΔΔCt method according 
to the manufacturer's protocol. The relative gene expression was calculated 
as a ratio to GAPDH. 
 
3.8. Single cell force spectroscopy 
3.8.1.   Substrate preparations for AFM experiments 
 
We have used collagen type-I (Col-I)-coated glass cover slips and SCP1 
monolayers as substrates for the AFM force spectroscopy experiments within 
the same culture dish lid. To form SCP1 monolayers, SCP1 cells were grown 
on untreated culture dish lids (petri dish 35 X 10mm, nunc A/S, Roskilde, 
Denmark) for two days at 37 °C, 5% CO2. Prior to use, they were washed with 
and covered by 1.5ml fresh serum-free MEM-Alpha medium (Invitrogen, 
Karlsruhe, Germany) supplemented with 15mM Hepes (Sigma-Aldrich, 
Germany) resulting in a CO2 independent measurement medium. For cell to 
Col-I measurements glass cover slips (Ø 15mm washed in 70% ethanol and 
distilled water) were coated with Col-I (100µg/ml) at 4°C overnight. Prior to the 
cell adhesion measurements, the Col-I-coated cover slips were placed on top 
of the SCP1 monolayer in the culture dish lids (as depicted in Fig. 12). An 
additional glass cover slip coated with BSA (0.5%w/v) at 4°C overnight was 
placed on top of another section of the SCP1 monolayer and it was used for 
cell capture. The culture dish lid, containing all three types of substrates (BSA, 
Col-I and SCP-1 monolayer) was then mounted on a temperature-controlled 
stage in the AFM and it was left to equilibrate for 10 min in ambient air at 
37°C. 
 
3.8.2. AFM setup and collection of the force spectroscopy data 
 
As shown in Fig. 12 and 25, we used Col-I-coated glass cover slides, SCP1 
monolayers and BSA-coated glass cover slides (control) as substrates for 
AFM force spectroscopy experiments. Fresh serum-free Alpha-MEM medium 
supplemented with 15 mM Hepes (Sigma-Aldrich) was used as measurement 
media throughout all force spectroscopy experiments. The culture dish lid, 
containing BSA and Col-I coated substrate as well as the SCP1 monolayer 
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was mounted on a temperature-controlled stage in the AFM and was left to 
equilibrate for 10 min at 37°C. Force Spectroscopy experiments were 
conducted using a NanoWizard II together with a CellHesion module (JPK 
Instuments, Berlin, Germany), mounted on a Zeiss Axiovert 200 M (Carl 
Zeiss, Goettingen, Germany) with a custom made temperature unit for 37°C. 
The force sensors used for force spectroscopy were tipless silicon nitride 
cantilevers with a nominal spring constant of 0.01 N/m (Tipless, MLCT-O10, 
Veeco, USA). Prior to cell adhesion experiments, the force sensors were 
coated overnight with 100 mg/ml Poly D-Lysine (PDL, Millipore, USA). The 
spring constants of the force sensors were determined individually by the 
thermal noise method.  
Either a PC3 or a LNCaP cell resting on the BSA coated coverslide was 
allowed to firmly adhere to the PDL coated tipless force sensor (Fig. 7) [101]. 
Force-distance curves were recorded while the piezo traveled in a closed loop 
up to 20 µm at an approach velocity of 7 µm/s until a trigger force of 100 pN 
was reached. Subsequently at a retraction velocity of 3 µm/s, the adhesion 
force signature was recorded (Fig. 5B).  
 
 
Figure 7: PC3 cell is attached on AFM tipless cantilevers used as a probe for single cell force 
spectroscopy experiments on substrates (A) Col-I-coated slide (B) SCP1 cell monolayer 
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3.8.3. Latrunculin-A treatment of a cell on the cantilever  
 
PC3 cells were prepared as described above for force spectroscopy 
experiments. One of the cells was captured from the BSA surface and 
attached to the PDL coated cantilever. Initially 60 force curves were collected 
on Col-I substrate with this cell, to check for normal adhesion properties (data 
not shown). (Subsequently Latrunculin-A (Sigma-Aldrich, USA) was added 
into the measurement medium until a final concentration of 0.2 μM was 
reached. After a period of 15 minutes for allowing Lat-A to disrupt the actin 
cytoskeleton, 60 additional curves were recorded with the same cell. In total 4 
different cells were treated and measured in this way.  
 
3.8.4. Elasticity measurements of the prostate cancer cells 
 
From AFM adhesion force spectroscopy curves, we determined the Young’s 
modulus from both LNCaP and PC3 cell types to estimate the contact area at 
a given contact force. We have analyzed 800 force curves of 9 cells from 
each cell type to determine the Young`s modulus of the cells (Fig. 11). The 
Young`s modulus of the cells were determined using Hertz model assuming 
the intender is in a spherical geometry. The radius of the spheric cell was 
assumed to be approximately 10 μm. 
 
3.8.5. Force spectroscopy data evaluation 
 
For data analysis only the retraction parts of the approach-retract cycles were 
evaluated. In order to obtain characteristic quantitative information from the 
force-distance curves, a custom-designed data evaluation and step detection 
software [102] was used to denoise the signal (black lines in Fig. 5B), find the 
baseline (dashed lines in Fig. 5B), correct for hydrodynamic drag and 
possible drift. Furthermore we extracted the following parameters from the 
force spectroscopy curves [101]:  
 
a) step height [pN] describing the difference in force measured before and 
after an individual detachment event, visible as a force step. The algorithm 
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identifies such a step by maxima in the derivative of the denoised signal that 
surmount a certain threshold and marks it by a small red cross (Fig. 5C). The 
last step in a force curve is the most reliable one since in contrast to all other 
(intermediate) steps no other connection between cell and substrate persists.  
b) adhesion rate [%] describing the fraction of curves with at least one 
detected force step. 
c) number of steps describing the average number of steps detected per 
curve (only counting curves with at least one detected force step). 
d) step position [mm] describing the distance between the contact point 
(black circle at the intersection of baseline and retrace curve) and a force 
step. 
e) work of detachment [aJ] describing the energy dissipated during that 
force experiment by integrating the area between baseline (zero force) and 
retract curve. (Note: this has no trivial relation to the adhesion energy. In fact, 
velocity dependent viscous and plastic deformation of the cell and the cell 
membrane itself strongly contribute to the work of detachment far from the 
thermodynamic equilibrium). 
f) detachment force [pN] describing the highest measured adhesion (global 
maximum) per curve. 
g) plateau steps, for this set of data appear after a force plateau of at least 
500 nm length at loading rates of less than 27pN/s (see step in Fig. 30B). At 
loading rates between 27 and 40 pN/s the criterion was not clear enough to 
avoid false positive or negative step discrimination. 
h) steep (jump) steps consequently occur after an increase in force of at 
least 40 pN/s (See steps in Fig. 30A). 
 
3.8.6. Density plots of tethers and jumps  
 
We also analyzed force-loading rates (slope of the force trace) prior to each 
step. Due to a constant velocity of 3 µm/s the loading rate was directly derived 
from the force-distance trace. Steps were defined as plateau steps (tethers) 
with loading rates less than 24 pN/s (~slope of 8 pN/μm) and as steeper steps 
(jumps) with loading rates higher than 36 pN/s (~slope of 12 pN/μm). We have 
normalized the data relative to the total number of steps in each group and 
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plotted slope versus positions (in logarithmic scale for a better visualization) 
and created 2D maps of the data and finally smoothed it using a computer 
algorithm with the bin intervals of x and y axes: 
Sigma x = 0.1 
Sigma y = 5 
 
3.9. Statistical analysis 
 
An unpaired t-test assuming unequal variances was used to analyze the 
adhesion rate, the average number of steps, percentage of F- & T-steps (in 
SCFC) by comparing the means collected from individual cell types with or 
without treatment of antibody on different substrates. The means were 
indicated as columns and error bars represent the standard error of the mean. 
Same t-test was used to compare the numbers of cell attachments on SCP1 
monolayers (in time lapse microscopy). 
A nonparametric Mann-Whitney test without assumptions was applied to 
compare Young`s modulus, detachment forces, step heights, works from all 
force curves between individual cells with or without treatment of antibody on 
different substrates. Medians are indicated as the middle line inside the box-
plot and boxes represents the quartiles of +/- 25% of the data from the 
median values. Error bars covers the whole data in which a few extreme 
values were excluded.  
 
3.10.    Softwares and websites used in the study 
 
For the evaluation of the force spectroscopy curves we have used a custom 
designed step detection algorithm [102]. Analyses of the collected data have 
been done with the Microsoft, Excel (2008) program. And statistical 
calculations were done with the StatPlus extension of the Microsoft, Excel 
program. 2D heat plots of the membrane anchoring data were done with the 
Mathematica software version number 9.0.1.0. The figures of the thesis were 
created with Adobe Illustrator and Microsoft PowerPoint.  
For the analysis of the images taken from time-laps, fluorescent and confocal 
microscopy data we have used ImageJ program, can be downloaded from the 
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website http://imagej.nih.gov/ij/. The literature searches were done with the 
websites Pubmed (http://www.ncbi.nlm.nih.gov/pubmed) and Web of Science 
(http://apps.webofknowledge.com/). 
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4. Results 
4.1. PC3 and LNCaP adhesion, proliferation and spreading in co-
culture with SCP1 
 
First, cell adhesion was analysed by using time-lapse imaging for up to 12 h. 
CFDA (Carboxyfluorescein diacetate) pre-labelled PC3 and LNCaP cells were 
plated on previously formed SCP1 monolayer. The added PC3 and LNCaP 
cells were monitored on the SCP1 monolayer and after 4 hours, most of the 
PC3 cells appeared spread on the SCP1 monolayer whereas the LNCaP cells 
appeared small and round (Fig. 8A). Microscope stage was moving 
automatically to place the plates on the objective. Because of plate shake off 
effect during imaging non-adherent cells were kept out of focus and excluded.   
Despite that the morphologies of the two cell types were different, only the 
adherent cells were included in all countings. Our quantitative analysis 
showed that approx. 90% of the PC3 cells were able to adhere to the SCP1 
monolayer already after 4 h and that their adhesion also remained close to 
90% after 12 h (Fig. 8B). In contrast, LNCaP cells had lower adhesion to 
SCP1 (approx. 25%), which did not increase significantly after longer 
cultivation time.  
 
 
Figure 8: Cell adhesion of PC3 and LNCaP cells on SCP1 monolayers analysed by time 
lapse imaging. (A) Phase-contrast and fluorescent microscopy of CFDA-labelled PC3 and 
LNCaP cells plated on SCP1 monolayers in 6-well dishes. Images are taken after 4 h. (B) 
Quantification of adherent PC3 and LNCaP cells after 4 and 12 h cultivation on SCP1 
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monolayers. The percentage of adherent cells was quantified first, by manual counting of the 
CFDA-labelled cells with the cell counter tool in Image J software and second, by comparing 
to the initial number of plated cells (approx.. 50x103 cells/well). In the images also a slight 
background of CFDA dye particles is visible (more apparent in the LNCaP image). The graph 
bars show mean ± SD of four independent experiments (p<0.0001, unpaired t-test). 
 
In order to investigate PC3 and LNCaP cell proliferation on SCP1 monolayers, 
we performed co-culture experiments for up to 8 days. Phase-contrast 
microscopy at day 1 and 8 demonstrated the formation and propagation of 
PC3 colonies on top of the SCP1cells, whereas LNCaP cells formed small cell 
clusters, which did not expand but rather regressed during this period (Fig. 
9A). Next, the co-cultured cells were counted at three different time points and 
the growth of PC3 and LNCaP was calculated by subtracting the cell number 
of SCP1 monolayers cultivated in parallel as controls. Our quantitative 
analysis confirmed the microscopy observation that PC3 cells, but not LNCaP 
cells, were able to divide and further expand on SCP1 cells (Fig. 9B).  
 
 
Figure 9: Expansion of PC3 and LNCaP cells on SCP1 monolayers (A) PC3 and LNCaP 
cells (approx.. 20x103 cells/well) were grown on SCP1 monolayers in 6-well dishes for up to 8 
days. Phase-contrast images demonstrated the formation and propagation of PC3 colonies 
(outlined) on the top of SCP1 cells between day 1 and 8. In contrast, LNCaP cells formed 
small cell clusters (arrows) that did not expand but rather regressed by day 8. (B) 
Quantification of PC and LNCaP cell numbers after 1, 5 and 8 days of cultivation on SCP1 
monolayers. The proliferation of PC3 and LNCaP cells was calculated by subtracting the 
SCP1 control monolayers from the total cell count of the co-culture. The graph shows mean 6 
± SD of three independent experiments for each time point (p<0.0001, unpaired t-test). 
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To find out how much cells could spread when they cultured on the surfaces, 
Shape analysis of the cells PC3 and LNCaPs were carried out by calculating 
their flatness shape factor. As shown in Fig. 10A, PC3 cells grown on glass or 
Col-I-coated glass have a lower flatness shape factor compared to LNCaP 
cells, indicating a higher capacity to spread. However, shape analysis of both 
cell types cultivated on SCP1 monolayers were not carried out due to the risk 
of inaccurate measurements of area, diameter and volume due to the 
underlying cell bodies of the SCP1 cells. In contrast to the data given in Fig. 
9B, when cultivated on polystyrene (without SCP1 cells), PC3 and LNCaP 
cells, have comparable proliferative capacity (Fig. 10B). Hence, we concluded 
that PC3 cells have a strong affinity towards SCP1 cells in terms of cell 
adhesion and proliferation. 
 
 
Figure 10: (A) Flatness shape factor of PC3 and LNCaP cells, cultivated on glass or Col-I 
coated glass slides, was calculated as described in Docheva et al [57]. The results revealed 
that PC3 cells are flatter on both surfaces compared to LNCaP cells. Graph bars represent 
mean ± SD of at least three independent AFM scans for both cell type on each surface. (B) 
Analysis of PC3 and LNCaP proliferation on polystyrene. Both cell types were cultivated in T-
75 flasks and during passaging over a period of 24 days their number was recorded. 
Cumulative population doubling (cum PD) and population doubling time (PDT) were 
calculated as described in Huang GT et al 2006 [103]. The obtained results demonstrate that 
in a non co-culture condition both cell types have comparable proliferative capacity. In the 
calculation of PDT, graph bars represent mean ± SD of the different passages for each cell 
type. 
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4.2. Calculation of Young`s modulus of PC3 vs LNCaP cells 
 
Cells, which are attached on the tipless AFM cantilevers, were used as a 
probe to elucidate their adhesion behaviors toward different substrates 
specifically SCP1 monolayer and Col-I. The contact area of a cell has an 
important impact on its adhesion to a given substrate when a contact force is 
applied on them. Elasticities of the PC3 and LNCaP cells were calculated in 
order to shed light on the contact area of the cells to the surface when they 
were used as a probe on AFM cantilever. In principle higher contact area 
predicts more adhesion. When a force is applied on a cell during contact to 
the substrate, as expected contact area of the softer cells will be higher than 
the stiffer ones. But it does not mean that when they have higher contact 
area, LNCAP cells has a higher adhesion than PC3 cells, because adhesion 
is primarily related with the number of adhesion molecules present on the cell 
membrane that contact to the substrate. We have measured the Young`s 
modulus of the cells when they were used as a probe on an AFM cantilever. 
In accordance with earlier measurements [57], PC3 cells appeared 
significantly stiffer than LNCaP cells (Fig. 11). This result showed that LNCaP 
cells probed a larger contact surface than the stiffer PC3 cells with contact 
forces of 100 pN for all cells. Consequently, a larger contact surface will 
contribute higher to LNCaP cells adhesion to the probed substrates when 
compared with PC3 cells.  
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4.3. Quantification of the short-term adhesion of PC3 and LNCaP cells 
on Col-I coated surfaces and SCP1 monolayers 
 
Cell to cell and cell to matrix adhesion experiments were performed in cell 
culture dishes with PC3 or LNCaP cells. In our experimental set up one of 
these cells was immobilized on the AFM cantilever (Fig. 12), while SCP1 and 
Col-I were used as substrates in the cell culture dishes. The prostate cancer 
cell on the AFM cantilever was then brought into contact with Col-I or the 
SCP1 monolayer for a predefined contact time (0.3 s) and with a predefined 
contact force (100 pN). Afterwards, the force necessary to withdraw the 
prostate cancer cell from each of the substrates was recorded. The resulting 
force-distance curves (Fig. 13) contain detailed information about the cellular 
interaction forces on the molecular level [96,97,104].  
 
Figure 11: Young`s modulus 
of PC3 and LNCaP cells 
attached on AFM cantilevers.  
(A) Red crosses represent 
the median values of the 
young`s modulus of 
measured 18 cells. (B) 
Middle line on Box-plots 
shows the median value of 
the corresponding Young`s 
modulus values for 800 force 
distance curves. Whole box 
range covers the +/- 25% of 
the data from the median 
value. A significant p-value 
from a nonparametric Mann 
Whitney test of the “PC3” 
versus “LNCaP” versus is 
marked by * (p < 0.01) 
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Figure 12: Schematic representation of the experimental setup. Single cells from two 
different prostate cancer cell lines (PC3 and LNCaP) were immobilized to a tipless AFM 
cantilever (force sensor) in order to study their interaction forces with the apical surface of a 
SCP-1 monolayer (representing mesenchymal stem cells) or with Col-I (representing bone 
matrix) [101]. 
 
Fig.13 shows representative force traces indicating typical multiple de-
adhesion events for PC3 cells and single de-adhesion events for LNCaP cells 
on Col-I and SCP1 substrates. The evaluation of these force curves confirms 
that PC3 cells exhibit a greater affinity than LNCaP cells to SCP1 cells and 
Col-I. In order to evaluate these rather complex force-distance curves a step 
detection algorithm [102] was applied to locate de-adhesion events and to 
quantify the corresponding forces despite the varying levels of noise.  
 
 
Results 43 
 
Figure 13: Characteristic force curves from each of the four different types of experiments 
are represented. (A) LNCaP on Col-I, (B) LNCaP on SCP1 monolayer, (C) PC3 on Col-I and 
(D) PC3 on SCP1 monolayer [101]. 
 
We have calculated the adhesion rates for the corresponding interactions and 
number of steps in each force curve to see how often PC3 and LNCaP cells 
can form adhesion events to their substrates. The force measurements of 
PC3 on Col-I showed an overall adhesion rate of more than 50%, whereas the 
adhesion rate of LNCaP on Col-I was around 30% (Fig. 14A). A similar 
behavior in adhesion rates was found on SCP1 surfaces, where PC3 had an 
adhesion rate of more than 45% while the adhesion rate of LNCaP was less 
than 30% (Fig. 15A). Also, the average number of de-adhesion force steps 
from force curves, containing at least one de-adhesion event, is significantly 
higher for PC3 than for LNCaP, both on Col-I and SCP1 monolayer substrates 
(Fig. 14B and Fig. 15B). This means firstly, that PC3 cells can form higher 
numbers of binding events than LNCaP cells and secondly, affinities for Col-I 
and SCP1 substrates are higher for PC3 cells than LNCaP cells.  
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Figure 14: Adhesion rates (percentage of the force curves which have at least one de-
adhesion event) and average number of steps in these force curves (which have at least one 
de-adhesion event) of PC3 and LNCaP cells on Col-I monolayer substrates. Mean values of 
at least 10 cells for A) adhesion rates and B) average numbers of steps of PC3 and LNCaP 
cells are indicated with red crosses and mean values of the measured total number of cells 
given as columns. Double-error bars show the standard error of the means. P-values from an 
unpaired t-test of the “PC3” data versus “LNCaP” are marked by *(p<0.05) 
 
 
Figure 15: Adhesion rates and average number of steps in these force curves of PC3 and 
LNCaP cells on SCP1 monolayer substrates. Mean values of at least 10 cell for A) adhesion 
rates and B) average numbers of steps of PC3 and LNCaP cells are indicated with red 
crosses and mean values of the measured total number of cells given as columns. Double-
error bars show the standard error of the means. P-values from an unpaired t-test of the 
“PC3” data versus “LNCaP” are marked by *(p<0.05) 
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We have measured the heights of the individual de-adhesion steps in each 
force curve and the positions of these steps. The heights and positions of the 
steps could vary depending on what kind of bonds were used by the cells 
during their interactions with their substrates. The forces of the individual de-
adhesion steps appeared slightly higher for PC3 cells on both Col-I substrate 
and SCP1 monolayer, when compared to LNCaP cells (Fig. 16A and Fig. 
17A). Because the step force values of the last adhesive event in a force 
curve did not significantly differ from the values of intermediate steps, all 
adhesive events were included into the evaluation. Since the force distribution 
did not follow a Gaussian distribution, Fig. 16 and Fig. 17 depict medians and 
quartiles. For PC3 cells the median was at 17.4 pN on SCP1 monolayers and 
17.0 pN on Col-I. The step height medians of LNCaP cells, on the other hand, 
were 14.9 pN on SCP1 monolayers and 14.8 pN on Col-I. Control 
measurements of PC3 cells on bare glass surfaces incubated with BSA 
resulted in step forces below 13 pN (not shown).  
Significant differences between the two prostate cancer cell lines were also 
observed for step positions, i.e. the distance between PC cell and substrate, 
at which the bond rupture was detected (Fig. 16B and Fig. 17B). The 
adhesive bonds of PC3 cells break for both Col-I substrates and for SCP1 
monolayers roughly twice as far as the bonds of LNCaP cells. On Col-I 
substrate for PC3 cells, they finally break at a median distance of 0.7 µm (Fig. 
16B). On SCP1 monolayers this distance was even further at 1.1 µm (Fig. 
17B). The fact that these bonds rupture up to several micrometers away from 
the observed contact point between the two cell types or between cell and 
Col-I can be explained by either: a) extremely compliant cells; b) by 
membrane tethers, which are pulled out of the cell membrane by the external 
force; or c) by filopodia or other micro-extensions which are actively formed by 
the cells [101]. 
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Figure 16: Heights and positions of the individual de-adhesion steps for PC3 and LNCaP 
cells on Col-I substrates. Medians are indicated in the middle lines of Box-plots for A) heights 
of de-adhesion steps and B) step positions. Whole box range covers the quartile values (+/- 
25% of data from the median). Significant p-values from a nonparametric Mann Whitney test 
of the “PC3” and “LNCaP” versus the others are marked by *(p<0.01). 
 
 
Figure 17: Heights and positions of the individual de-adhesion steps for PC3 and LNCaP 
cells on SCP1 monolayers. Medians are indicated in the middle lines of Box-plots for A) 
heights of de-adhesion steps and B) step positions. Whole box range covers the quartile 
values (+/- 25% of data from the median). Significant p-values from a nonparametric Mann 
Whitney test of the “PC3” and “LNCaP” versus the others are marked by *(p<0.01). 
 
In each force curve detachment forces and work of detachments were also 
calculated. The quantity of these parameters shows the total force and energy 
needed to separate the cell from their substrates. This can tell us how strong 
these cells can bind to their substrates and give an idea about the 
involvement of the CAMs. Stronger detachment forces and higher energy 
were needed to separate the PC3 cells from both of the Col-I and SCP1 
substrates. PC3 adhesion to SCP1 was the strongest of the four measured 
interactions and the LNCaP cells were the weaker binders to both Col-I and 
SCP1 (Fig. 18 and Fig. 19). Control measurements on bare glass surfaces 
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incubated with BSA revealed the weakest interactions for all adhesion 
parameters (data not shown). 
 
 
Figure 18: Detachment forces and work done on force curves calculated for PC3 and LNCaP 
cells. Medians are indicated in the middle lines of Box-plots for (A) detachment forces and (B) 
work on Col-I substrate. Whole box range covers the quartile values (+/- 25% of data from the 
median). Significant p-values from a nonparametric Mann Whitney test of the “PC3” and 
“LNCaP” versus the others are marked by *(p<0.01). 
 
 
Figure 19: Detachment forces and work done on force curves calculated for PC3 and LNCaP 
cells. Medians are indicated in the middle lines of Box-plots for (A) detachment forces and (B) 
work on SCP1 substrate. Whole box range covers the quartile values (+/- 25% of data from 
the median). Significant p-values from a nonparametric Mann Whitney test of the “PC3” and 
“LNCaP” versus the others are marked by *(p<0.01). 
 
Tethers are viscous membrane tubes [105], which are pulled out of the cell 
membrane at a constant force and therefore exhibit a characteristic force 
plateau [106] (see section 4.8. Membrane and cytoskeleton anchoring of cell 
surface receptors). Filopodia, on the other hand, are not generated by the 
pulling force. They contain protruding actin fibers and already exist before the 
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cells are brought into contact with their substrate. Consequently, filopodia are 
expected to exhibit an initial force-free unbending phase, followed by a 
sudden increase in force when loaded at a distance from the contact point 
that corresponds to their initial length (steps as shown in Fig. 13D). Therefore, 
in contrast to tethers they lack a force plateau. The de-adhesion steps may be 
displayed as tether-like (t-like) and filopodia-like (f-like) jump steps in force 
curves as explained above. We have defined the steps first and then 
classified them as t-like (tether) or f-like (jump). And finally, the fractions of 
these t- and f- like steps were calculated. In the case of PC3 cells, more than 
50% of all detected steps exhibit these characteristic signatures of filopodia 
and less than 40% exhibit the typical signature of tethers. For LNCaP cells, on 
the other hand, less than 40% of the steps appear as filopodia like steps and 
about 45% as tether-like steps (Fig. 20). Furthermore, the step position of the 
filopodia-like steps of PC3 cells increased over time within the experiments at 
an average rate of 0.6 nm/s, while no significant change in step position was 
observed in LNCaP cells. 
 
 
Figure 20: Analysis of filopodia-like steps versus tether-like steps in both cancer cell types to 
(A) Col-I and to (B) SCP1 monolayer. Means of the percentage of individual de-adhesion 
steps representing the typical force pattern of filopodia-like steps (solid) and tether-like steps 
(striped) for the two cell lines PC3 and LNCaP. Error bars correspond to standard error of the 
mean. A significant p-value from a t-test between the different steps within a prostate 
carcinoma cell line is indicated by *(p,0.05). Due to the discrimination criterion, steps at 
positions shorter than 1 μm were not counted and therefore the ensemble size for LNCaP and 
on Col-I in particular was small. The number of uncounted steps, because the slope did not 
allow for a clear distinction between tether and filopodia (loading rates between 27 and 40 
pN/s) was less than 7%. 
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Consequently, PC3 cells showed specific binding to both bone related 
substrates. They have higher adhesion rates and adhesion forces than 
LNCaP cells. And also they have exhibited longer step positions, with specific 
signatures of filopodia-like steps. These results confirmed that the PC3 cells 
have a higher adhesive capacity on bone tissue, which may support them to 
stabilize in the metastatic site and subsequently to propogate. 
 
4.4. Integrin expression on PC cells 
4.4.1. Semi-quantitative PCR data 
 
To find out which receptors are possibly responsible for the increased affinity 
of PC3 cells to Col-I substrate and SCP1 cells, we investigated the expression 
of two major integrin receptors which have binding affinity to collagen type I, 
namely α1β1 and α2β1 in PC3 and LNCaP cells by using semi-quantitative 
PCR. Our results demonstrated that both receptor types are strongly 
expressed in PC3 cells, in contrast to LNCaP cells (Fig. 21).  
 
 
 
 
Figure 21: Investigation of integrin expression. 
Semi-quantitative PCR for α1β1 and α2β1 
integrins was performed with cDNA from PC3 and 
LNCaP cells and revealed a strong expression of 
both receptors in PC3 cells in comparison to 
LNCaP cells. The PCR results were reproduced 
independently three times (consider that the PCR 
experiments were done with 1:10 diluted cDNAs). 
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4.4.2.   Quantitative PCR data 
 
Expression levels of integrins α1, α2, α11, and β1, which constitute the Col-I 
binding cell surface receptors α1β1, α2β1 and α11β1, were assessed also by 
quantitative real time PCR. The results (Fig. 22) show that along with β1, 
which is a constituent of all three Col-I binding receptors, α2 was strongly 
expressed by PC3 cells, followed by α1, while α11 expression was not 
detectible in PC3 cells. In comparison, the lymph node-derived LNCaP cells 
expressed eight-fold lower levels of integrin β1 and none of the three α-
integrin subunits were detected. This data confirmed our findings in Fig. 21 
and furthermore, demonstrated that among the Col-I integrins the major 
receptor in PC3 is α2β1. 
 
Figure 22: Quantitative RT-PCR analysis of Col-I-binding integrin expression in PC3 (black) 
and LNCaP (gray) cells correlated to the GAPDH expression level. Error bars correspond to 
standard error of the mean of two independent experiments. 
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4.5.   Col-I expression on SCP1 monolayers  
 
To verify the expression of Col-I in our experimental system, we have applied 
primary antibody against Col-I molecules on the substrates in combination 
with secondary antibody, which emits green light at wavelength 488nm. The 
results were compared with the negative control experiments, which were 
missing primary antibody. We were able to detect the Col-I fibers on coated 
glass slides and extracellulary secreted Col-I molecules on SCP1 monolayers 
(Fig. 23 and Fig. 24). However, from confocal microscopy images of 
fluorescently labeled Col-I on SCP1 cells, the exact location of the collagen 
could not be unambiguously resolved as “on”, “in” or “below” the cell 
membrane. An image from the apical surface of the cell monolayer was given 
in Fig. 24. The collagen seems to be deposited in several layers of SCP1 
monolayer; top, middle and as well as below the cells. 
 
 
Figure 23: Immunofluorescence images of Col-I, labeled with AlexaFluor488 fluorescence 
dye appearing in green and cell nuclei stained with DAPI in blue. (A) On Col-I coated glass 
slide (B) SCP1 monolayer 
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Figure 24: Detection of the Col-I molecules on the apical surface of SCP1 monolayer labeled 
with AlexaFluor488 fluorescence dye using confocal microscopy (A) Confocal microscopy 
image of the SCP1 monolayer apical surface (Col-I deposited on cells perimeters are marked 
by red lines) (B) Confocal microscopy negative control image of SCP1 monolayer without 
using primary Col-I binding antibody. 
 
Consequently, our finding of extra cellularly expressed Col-I on the apical surface of 
the SCP1 cells may be one of the responsible partners for PC3 cell adhesion to this 
substrate. 
 
4.6. Long-term adhesion of PC3 cells with β1 integrin antibody 
blocking and collagenase treatment on Col-I coated surfaces 
 
In order to investigate the role of these Col-I binding cell surface receptors in 
PC3 adhesion to Col-I, we performed an optical density-based binding assay 
with untreated and anti-β1 integrin antibody treated PC3 cells on Col-I coated 
surfaces. In this assay, the relative number of adherent cells was determined 
after the cells were incubated for three different time periods. As negative 
control, we used untreated plastic surfaces and Col-I-coated surfaces, which 
were treated with collagenase, in order to proteolitically remove the accessible 
collagen. Fig. 25 shows the affinity of untreated and of anti-β1 antibody-
treated PC3 cells to Col-I coated surfaces, with or without collagenase 
treatment, which was evaluated by the optical adhesion assay. On Col-I, the 
adhesion rate of PC3 cells was approximately 40% after 30 min and over 90% 
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after 90 min. In contrast, after 30 min, PC3 cells incubated with β1 blocking 
antibody reached only 20%; however at 90 min, they could recover up to 80%. 
In contrast, PC3 cells on collagenase-treated and on bare plastic surfaces 
showed no pronounced differences as on both surfaces, we observed low cell 
adhesion, which even after 90 min reached only about 20%. These results 
show that collagenase treatment effectively deactivated the Col-I from the 
coated surfaces. Furthermore, β1 integrin blocking antibody could block the 
Col-I binding β1 integrins at least for short time periods (until 30 min, Fig. 
25B) but cells could renew afterwards their integrin receptors. 
 
 
Figure 25: Optical density 
measurements of adherent 
cells at three different time 
points as a fraction of the 
amount of PC3 cells 
originally plated on four 
different surfaces. (A) 
Control measurements of 
PC3 on Col-I coated (black) 
and bare plastic surfaces 
(gray). (B) Lined up black to 
light gray respectively as: 
PC3 cells on Col-I coated 
surfaces, β1-blocking 
antibody treated PC3 cells 
on Col-I coated surfaces, 
PC3 cells on Col-I coated 
and collagenase treated 
surfaces. Error bars 
correspond to standard 
deviations of 5 wells for each 
data point.  
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4.7. Short-term adhesion of PC3 and LNCaP cells on Col-I and SCP1 
surfaces with β1 integrin antibody blocking and collagenase 
treatment 
 
To quantify the binding strength of PC3 cells to Col-I and to the bone marrow-
derived SCP1 cell line, AFM-based single cell force spectroscopy was 
performed: An untreated LNCaP cell, or an untreated or an β1 integrin 
blocking antibody-treated PC3 cell resting on a BSA coated surface was 
allowed to firmly adhere to a poly-l-lysine coated (tip-less) AFM force sensor. 
Next, the cell was brought into contact with an untreated or a collagenase 
treated Col-I surface, or with an untreated or a collagenase treated SCP1 
monolayer, or a BSA coated control surface (Fig. 26). After a short contact of 
less than 0.3 seconds the force necessary to withdraw the cells from the 
addressed surface was determined.  
Figure 26: Experimental design for the AFM force spectroscopy characterizing the specific 
interaction of PC3 cells (expressing α1β1 and α2β1 integrins) with SCP1 cells or Col-1 
surfaces. A single cell was immobilized to the force sensor. LNCaP cells lacking these 
integrins, antibody blocking of β1 integrins on PC3 cells, collagenase treatment of Col-I or 
SCP1 substrates or nonspecific BSA substrates served as control experiments. 
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The force measurements of PC3 on Col-I surfaces showed an overall 
adhesion rate (percentage of force traces with adhesive steps) of more than 
60%, whereas the adhesion rates of LNCaP and PC3 cells blocked with β1 
antibody were lower than 40%, which is in the range of control measurements 
on the BSA coated surface. Adhesion rates of PC3 on collagenase treated 
Col-I substrates were a little higher than 40% but still significantly lower than 
adhesion rates on untreated Col-I. And also blocking of PC3 cells with the 
anti-β1 antibody, dropped the adhesion rate to about 30%, which is in the 
range of non-specific PC3 adhesion rates to BSA coated surfaces and LNCaP 
binding to Col-I (Fig. 27A). 
A similar behavior was found for the number of de-adhesion force steps per 
force curve (Fig. 27B). With approximately 1.9 steps per curve, the average 
number of steps was highest for PC3 cells on Col-I, which is significantly 
higher than the rest of the data. For PC3 with anti-β1 blocking on Col-I, 
LNCaP on Col-I and PC3 on BSA, we observed no pronounced differences 
within these groups. In these cases, the average number of steps was lower 
than 1.4 (Fig. 27B). So these results tell us that blocking of PC3 cells with the 
anti-β1 antibody as well as collagenase treatment of Col-I coated surfaces 
effectively decrease the cell adhesion to Col-I surfaces. 
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Figure 27: Adhesion rates and average number of steps in the force curves of PC3 and 
LNCaP cells on Col-I monolayer substrates. Mean values of at least 8 cell for (A) adhesion 
rates and (B) average number of steps of PC3 (+/- antibody) and LNCaP cells on Col-I (+/- 
collagenase) surfaces are given. Error bars shows the standard error of the means. P-values 
from an unpaired t-test of the “PC3 on Col-I” data versus the others are marked by *(p<0.05). 
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Our findings are different for the measurements performed on the SCP1 
surfaces. Treatment of SCP1 surfaces with collagenase solution did not result 
in significant difference for PC3 cells. PC3 cells showed adhesion rates higher 
than 55% and average number of steps higher than 1.5 steps per curve on 
SCP1 surfaces with or without collagenase treatment. For PC3 with anti-β1 
blocking on SCP1, LNCaP on SCP1 and PC3 on BSA, the adhesion rates and 
average number of steps are significantly lower. We observed no pronounced 
differences within these groups. In these cases, the adhesion rates were 30-
35% and the average number of steps was in the range of 1.3 steps per curve 
(Fig. 28A and B). Anti-β1 antibody also served as an adhesion blocking agent 
for PC3 cells on SCP1 surfaces, whereas collagenase treatment of SCP1 
surfaces did not show the same result. This suggests that adhesion of PC3 
cells with SCP1 cells is not mediated via the apical deposited Col-I matrix 
network, but goes through β1 integrin receptors on PC3 cell and a ligand 
expressed on SCP1 itself, which for now remains unidentified. 
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Figure 28: Adhesion rates and average number of steps in the force curves of PC3 and 
LNCaP cells on SCP1 monolayer substrates. Mean values of at least 8 cell for (A) adhesion 
rates and (B) average number of steps of PC3 (+/- antibody) and LNCaP cells on SCP1 (+/- 
collagenase) surfaces are given. Error bars show the standard error of the means. P-values 
from an unpaired t-test of the “PC3 on SCP1” data versus the others are marked by 
*(p<0.05). 
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Detachment forces are describing the highest measured adhesion (global 
maximum) per curve. We have measured 8 cells from each group and 
collected whole detachment forces data (from the force curves with at least 
one de-adhesion event) (Fig. 29). On Col-I surface without any treatment PC3 
cells have the highest detachment force values and significantly different from 
the rest of the data. On the other hand, Col-I surfaces collagenase treatment 
reduced the detachment force to the BSA level, whereas on collagenase 
treatment of the SCP1 surface did not have a significant effect on detachment 
forces (Fig. 29A and B). In both of the surfaces, it is clearly seen that 
blocking of the PC3 cells with beta-1 antibodies dropped the detachment 
forces significantly to the level of unspecific adhesion of BSA surface. The 
detachment forces of LNCaP cells on both of the surfaces were significantly 
lower than PC3 (Fig. 29A and B). Here, we can also conclude that the PC3 
cells use their β1 integrins to form these detachment forces when they adhere 
to SCP1 surfaces, and these integrins may have another ligand on SCP1 cells 
other than Col-I that is needed to identify.  
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Figure 29: Detachment forces of PC3 and LNCaP cells on Col-I, SCP1 and BSA surfaces. 
Box-plots of detachment forces of PC3 (+/- antibody) and LNCaP cells (A) on Col-I (+/- 
collagenase) and BSA (B) on SCP1 (+/- collagenase) and BSA surfaces. Medians are 
indicated in the middle lines of boxes. Error bars cover the whole range of data in which a few 
extreme values are excluded. Box ranges covers the quartile values (+/- 25% of data from the 
median). Significant p-values from a nonparametric Mann-Whitney test of the “PC3 on Col-I” 
and “PC3 on SCP1” versus the others are marked by *(p<0.01). 
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4.8. Membrane and cytoskeleton anchoring of cell surface receptors 
 
Although there is a clear difference in four of the parameters (adhesion rate, 
the average number of steps and the detachment force) quantifying the 
interactions, no information about the type of interaction and in particular 
about the anchoring of the relevant receptors to their respective micro-
environment can be obtained from these parameters. To gain more detailed 
insight into the type of interaction and the receptor anchoring to the cell 
membrane or cytoskeleton, we displayed the parameters position of steps 
[μm] and slope prior to each step [pN/μm] in two-dimensional (2D) probability 
density maps. 
Receptor-ligand interactions of receptors linked to the cytoskeleton typically 
exhibit a clear rise in force, just before the unbinding event, just like the force 
curve displayed in Fig. 30A [107]. These kind of steps are characteristic of the 
rupturing of a transmembrane-receptor which is firmly connected to the 
cytoskeleton on its intracellular side [108]. On the other hand, long plateaus 
with slopes around zero, as displayed in Fig. 30B, are typical of tethers being 
pulled out of the cell membrane [106,109,110]. Here, the constant force prior 
to the unbinding event is caused by the constant tension of the plasma 
membrane. 
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Figure 30: Two subsequent force traces (blue) from separating a PC-3 cell from a collagen 
substrate at a velocity of 3 µm/s after contacts of 0.3 s at 100 pN. Red crosses mark steps; 
the black line is the smoothed force trace. A turquoise line-fit indicates the slope prior to a 
step. (A) Jump like steps appear at slopes below -10 pN/µm (loading rates of -30 pN/s). (B) 
Tether like steps, caused by membrane tubes pulled from the cell by bonds not anchored to 
the cytoskeleton show typically slopes of 0 ±10 pN/µm. 
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The probability distribution of the force curve slope of each step versus the 
position of each step is visualized in density plots for the substrates SCP1 and 
Col-I in Fig. 31A and B. The step distribution observed for PC3 cells on SCP1 
and Col-I displays one strong peak in the jump region, indicating mainly cell 
surface receptors, which are well connected to the cytoskeleton. On the SCP1 
monolayer, the peak position is shifted by about 1 µm (dashed circle at 1.6 
µm), which can be explained by the fact that the SCP1 cells are much more 
compliant than the rigid Col-I substrate (dashed circle at 0.6 µm) [111]. On 
Col-I, a second, weaker peak can be observed in the tether region at about 
2.8 µm.  -10 pN/µm slope was picked as a border between tether and jump 
regions according to calculations made through histogram of tether steps 
identified by eye on PC3-Col-I data. The half width of the Gaussian 
distribution fitted to this tether distribution marks the -10pN/µm line chosen as 
a guide for the eye to separate between more tether like steps and more jump 
like steps.   
 
 
Figure 31: Probability density maps of force loading rates (slope of the force distance trace) 
prior to each step versus the step position. (A) PC3 cells on SCP1 monolayers (B) PC3 cells 
on Col-I coated glass slide. The y-axes (step position) in 2D maps are in logarithmic scale. 
 
On SCP1 substrate, with collagenase treatment the jump peak is shifted 
further (out of the dashed circle) to around 2 µm (Fig. 32A). These filopodia-
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like steps (jumps) are mainly indicating cytoskeleton connected receptors in 
longer step positions. With collagenase treatment of the Col-I substrate, PC3 
cells showed a broad peak between the tether and the jump region at 
positions around 2 µm and a peak in the jump region is shifted to step 
positions around 1 µm (Fig. 32B). 
 
Figure 32: Probability density maps of force loading rates (slope of the force distance trace) 
prior to each step versus the step position. (A) PC3 cells on collagenase treated SCP1 
monolayers (B) PC3 cells on collagenase treated Col-I coated glass slide. The y-axes (step 
position) in 2D maps are in logarithmic scale. 
 
With the application of beta-1 blocking antibody to PC3 cells, the probability of 
occurring unspecific adhesions was increased. (Note that the density plots are 
normalized and the colors do not reflect the adhesion rate). And on SCP1 
surface with the application of the β1 integrin blocking antibody, steps are 
concentrated at the same region but with a less intense peak  (Fig. 33A). This 
suggests that in addition to β1 integrins, other receptor-ligand interactions 
might be involved in PC3-SCP1 interactions. With the blocking of β1 integrins, 
the filopodia-like jump steps seem to be replaced mostly by tethers forming 
two pronounced peaks there at about 1.4 and 3.5 µm on Col-I substrate (Fig. 
33B). This result showed that these specific filopodia like jump steps mostly 
replaced by unspecific membrane bounded tether steps on Col-I substrate. 
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Figure 33: Probability density maps of force loading rates (slope of the force distance trace) 
prior to each step versus the step position. (A) PC3 cells treated with β1 integrin blocking 
antibody on SCP1 monolayer (B) PC3 cells treated with β1 integrin blocking antibody on Col-I 
coated glass slide. The y-axes (step position) in 2D maps are in logarithmic scale. 
 
In case of tether signals on force curves, there may be differences on their set 
up. Additionaly in the force curves of PC3 cells we have detected some 
special signatures of filopodia, which are steps rise with a negative slope (like 
a jump step), then continue with a constant force and then ruptures at some 
distant position like a common tether curve (Fig. 34A). We called these 
specific signatures as “filopodia-like tether curves”. 
 
Figure 34: Specific signatures which were detected in tether steps of force curves. (A) 
Filopodia tethers result from actin-rich elongated membrane protrusions (B) Continuous long 
membrane tethers result from membrane attachments, which are not linked to cytoskeleton. 
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Last, we have performed additional control experiments to further validate that 
the obtained interactions of PC3 cells with Col-I and SCP1 were specific. 
Lantrunculin-A was used to destroy actin cytoskeleton of the cells. This action 
of the drug was tested on PC3 cells and results of the latrunculin treatment 
can be seen on Fig. 35. Well established actin network of PC3 cells can be 
seen on Fig. 35A. Treatment of PC3 cells with latrunculin for 15 min cause 
them to lose their F-actin cytoskeleton, shrink and then form small round cells 
(Fig. 35B). Latrunculin-A is a drug which distrupts the actin cytoskeleton by 
binding and sequestering the g-actin [112].  
 
 
Figure 35: Fluorescent images of phalloidin labeled cells. (A) PC3 cells without treatment. 
Actin cytoskeleton of the cells is visible, cells were highly spreaded on the Col-I coated 
surface (B) PC3 cells after 15 min treatment of 0.2 μM latrunculin-A. The F-actin fibers are 
destroyed leading to collapse of cell shape into sphere. 
 
We have treated PC3 cells with Latrunculin-A to see the cells adhesion 
behaviors without direct participation of the actin cytoskeleton. PC3 cells 
without their intact actin network could not generate jump signals and also 
“filopodia-like tethers” on the force curves were absent which means that they 
lose their cytoskeleton connected membrane attachments to their substrates 
(Fig. 36A). On the BSA control surface (Fig. 36B), the density distribution 
resembles a characteristic way of unspecific binding; steps are accumulated 
in the center not obviously clustered in any of the jump and tether regions. 
Interestingly the control measurements with LNCaP cells on the Col-I (Fig. 
36C) show a single peak in the tether region, whereas several peaks are 
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distributed along the density map in both tether and jump regions at different 
step positions for LNCAP cells on SCP1 monolayers (Fig. 36D). 
 
Figure 36: Probability density maps of force loading rates (slope of the force distance trace) 
prior to each step versus the step position. (A) Latrunculin-A treated PC3 cells on Col-I 
substrate. (B) PC3 cells on BSA substrate (C) LNCaP cells on BSA Col-I substrate (D) 
LNCaP cells on SCP1 monolayer. The y-axes (step position) in 2D maps are in logarithmic 
scale. 
 
In the interaction of PC3 cells to Col-I and SCP1 substrates, we mainly 
detected jump and filopodia-like steps, which shows that these interactions 
were substrate specific. And when these interactions were blocked with anti 
β1 integrin antibody and when the cells actin cytoskeleton was distrupted with 
latrunculin-A on Col-I substrates, these specific signals were changed mainly 
to membrane tethers. Taken together, these results suggest that PC3 cells 
are using cytoskeleton connected integrin adhesion complexes and their 
filopodia like structures in these interactions. 
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5.     Discussion 
 
Prostate cancer (PC) is one of the leading cancer type among men and cause 
of death in Europe [113]. The ability of prostate cancer cells to metastase into 
bone tissue is very often event in these cases. Therefore, in the main focus of 
this study was to investigate in great detail the interaction forces of prostate 
cancer cells with the bone marrow-derived substrates namely, Collagen-I 
(Col-I) protein and mesenchymal stem cells (SCP1 cell line)  
 
Relevance of the methods used in the study to investigate PC cell 
interactions with the bone marrow substrates 
We used two types of PC cells, which are PC3 and LNCaP cell lines. PC3 is a 
bone metastasis-originated cell line that is highly differentiated type [114]. 
LNCaP is a lymph node metastasis-derived cell line that is moderately 
differentiated type [115]. We have used as substrates two different kind of 
surfaces, namely the bone extracellular matrix protein Col-I and the bone 
marrow residing mesenchymal stem cells (MSC, SCP1 cell line). We have 
investigated the expressionof collagen-binding integrins (α1, α2, α11 and β1) 
in the two PC cell types by isolating total cell RNA, then synthesing cDNA, 
and finally performing semi-quantitative and quantitative PCR. Cell adhesion 
and proliferation assays were used to see long-term adhesion of cells and 
theirpropagaton abilities on these surfaces. AFM-based single cell force 
spectroscopy (SCFS) was implicated to study short-term adhesion events as 
well as single cell adhesion forces. SCFC is a method that uses a whole vital 
cell as a probe and which allows viewing of single molecule interactions. 
Hence, SCFS represents an additional important tool to look deeper into the 
adhesion mechanisms.  
As mentioned above we investigated the binding efficiency of PC3 to Col-I 
and bone marrow-derived SCP1 cells by long-term adhesion assays (optical 
density-based and fluorescence-based) and by AFM-based single cell force 
spectroscopy. Both approaches highlight different aspects of the cellular 
interactions between prostate cancer cells and mesenchymal stem cells. The 
optical density- and fluorescence-based adhesion assays provide insights into 
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the time evolution of the cell-substrate interactions on a whole cell population 
level, while force spectroscopy experiments focus on interactions immediately 
after the cells have been brought into contact with their respective binding 
partners on a single cell level. Hence combining both types of methods result 
in a more fundamental understanding of cancer cell interactions with their 
metastatic environment from initial formation of adhesion and the forces 
involved to long-term interaction between cells. 
 
PC3 cells differed from LNCaP cells in means of adhesion, spreading 
and proliferation onto bone marrow components 
Previous studies using optical microscopy as well as AFM imaging already 
showed that PC3 cells adhere and proliferate much better than LNCaP cells 
on Col-I, and that PC3 adhesion, proliferation, and cell stiffness was 
significantly enhanced on Col-I, compared to other ECM proteins, such as 
fibronectin [57].  
Time-lapse microscopy observations allowed us to have a detailed look on the 
behavior of the PC cells when they were cultured on MSC monolayers (SCP1 
cell line). We have tried to answer the following questions: 1) how cells 
adhere to this substrate; 2) how was their cell shape affected; and 3) how 
effectively they could proliferate on SCP1. From the first hours of co-
cultivation up to several days in culture, prostate cancer cells derived from 
bone metastasis (PC3) proliferated and spreaded well on SCP1. In contrast 
the control group, which was derived from lymph metastasis (LNCaP), were 
rounder in shape and could not spread on SCP1, not only showed much 
fewer adherent cells during the initial hours of co-cultivation, but the number 
of cells further decreased after five days in culture. These results clearly 
demonstrated that PC3 cells are much adapted to survive on bone marrow 
cells. 
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The attachment forces involved in cell-to-cell and cell-to-matrix 
interactions were higher for PC3 cells than LNCaP cells 
To obtain a deeper insight into the nature of the observed cell-cell and the 
previously described cell-matrix interactions, we quantified the interaction 
forces on the single cell level using AFM based force spectroscopy. With the 
AFM, interaction forces of a much smaller number of cells can be determined 
quantitatively on the single cell level. This approach concentrates on forces 
arising during the initial cellular contact, since the cell was not allowed to 
develop the cell contact for more than 0.3 seconds before it was retracted and 
forced to unbind. Although, as mentioned above, AFM only probes the initial 
cellular contacts, the results we obtained were in agreement with our optical 
microscopy data, as well as with previous findings [57]. On both Col-I and on 
the SCP1 monolayer, the percentage of cellular interactions (adhesion rate), 
the number of interactions per successful force experiment (number of steps), 
the step position, the force of a single interaction event (step height), the 
detachment force, and the total work of detachment were larger for PC3 than 
for LNCaP. Our findings clearly reported that PC3 cells are very distinct from 
LNCaP cells in regards to their adhesive behavior. In particular, PC3 cells 
showed significantly stronger adhesion on both substrates (Col-I and SCP1), 
when compared to LNCaP. Due to their smaller Youngs` modulus (Fig. 11), 
LNCaP cells had a larger contact area during adhesion experiments with the 
AFM force spectroscopy. The same finding was also true for when these cells 
spreaded on cell matrix proteins such as Col-I and fibronectin. When they 
spreaded on cell matrix protein- coated surfaces, they could build up their 
cytoskeleton network and become stiffer than when they were attached on 
PDL-coated AFM cantilever. One of the other possible reason of having stiffer 
cells when they were spreaded on surfaces is that underlying glass was 
sensed during measurements. In this case, they had Youngs` Moduli at kPa 
range. PC3 cells were more than 2-fold stiffer in comparison to LNCaP cells 
[57]. In any case PC3 cells seem to be well adapted for invasion of bone 
substituents with their high capability of forming strong adhesion to these 
substrates. 
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Extracellularly secreted Col-I participation in the interactions between 
PC3 cells and SCP1 cells 
Cells could form their own extracellular matrix network. SCP1 cells did the 
same when they are cultured and build up a meshwork of extracellular 
materials. Furthermore, within each individual cell line, PC3 or LNCaP, both 
cell lines showed similar results in the parameter values extracted from the 
AFM measurements on Col-I and on SCP1 (Fig. 14 to Fig. 19). The only 
difference was that the step position was shorter on Col-I and larger on SCP-1 
monolayers due to the fact that the cells of the monolayer contributed their 
compliance and membrane tethers and henceled to enlargement of the 
interaction distances. These findings indicated that the adhesion of the 
prostate cancer cells to SCP1 cells could be mediated mainly by their 
interaction with Col-I, which was found by us and others to be expressed 
extracellularly by MSCs also on their apical side [101,116,117]. This 
observation was confirmed by immunofluorescence staining of Col–I in SCP1 
cells and on the Col–I-coated microscope slides, which both showed a strong 
fluorescence signal (Fig. 23 and Fig. 24). With this result, we concluded that 
in the interaction of PC3 cells to SCP1 cells, contributing effect of Col-I to the 
adhesion should be taken into account which is subject for further 
experiments.  
 
Col-I-binding integrin expression levels were higher in PC3 cells 
compared to LNCaP cells 
Integrins are cell surface receptors responsible for adhesion of cells to e.g. 
extracellular matrix proteins. We have investigated the role of the Col-I 
binding integrin receptors α1β1, α2β1 and α11β1, in the interaction of prostate 
cancer cells with the extracellular matrix protein Col_I and human MSC. 
Quantitative PCR of these Col-I binding integrin receptor subunits revealed 
that α1, α2 and β1 integrins are expressed in PC3 cells, and that α2β1 is the 
most abundant of these receptors in the PC3 cell line. On the contrary LNCaP 
cells showed only very low expression level of β1 integrins (Fig. 22). In this 
study, the partner α subunit in LNCaP cells was not determined. Consistent 
with previous literature reports showing that PC3 cells express a number of 
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Col-I- binding integrin receptors [55,97], while LNCaP cells lack some of these 
integrins [56], we showed that α1β1 and α2β1 integrins are potential 
candidates to mediate the detected force patterns. Moreover, our PCR results 
suggest that among the two receptor combinations α2β1 is the dominant one 
in PC3 cells. 
 
Collagenase treatment effectively degrades Col-I from coated surfaces 
and caused a reduction in cell adhesion  
Next, we blocked these interactions by either incubating the PC3 cells with an 
antibody against β1 integrin or by treating the Col-I substrate with 
collagenase. The optical density-based adhesion assay showed that the PC3 
cells adhered well to Col-I-coated surfaces, which is in agreement with our 
previous studies [57]. Moreover, in the present study we also applied 
collagenase treatment as a control to inhibit the interactions of PC3 with the 
Col-I-coated surfaces and found strong reduction of PC3 adhesion to this 
substrate: the percentage of adherent cells dropped to the levels observed on 
the control uncoated plastic surface (Fig. 25). This result proved that the 
collagenase treatment effectively hydrolyzed accessible Col-I molecules and 
reduced the number of binding events on the substrate to the level of the 
untreated control surface. 
 
Blocking of β1 integrin reduced the PC3 binding to Col-I  
When PC3 cells were blocked with the anti-β1 antibody, the fraction of 
adherent cells initially decreased on Col-I-coated substrates, however, after 
an incubation time of 90 min, the cells started to recover from the blocking 
effect. Nevertheless, the number of adherent cells still remained lower than 
the one observed for PC3 cells without antibody treatment (Fig. 25B). This 
observed recovery of PC3 affinity to Col-I could be the result of integrin 
turnover which provides fresh β1 subunits for the formation of new functional 
integrin receptors on the cell surface. Yuan et al analyzed the dynamics of the 
integrin adhesion complexes in long-term cell-ECM adhesion and found that 
these complexes undergoe integrin turnover by assembling and 
disassembling their units in time scales of 2-7 minutes  [118]. 
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PC3 to MSC interactions were mainly mediated via β1 integrin receptors 
Force spectroscopy results showed that the antibody blocking clearly inhibited 
the interactions on both Col-I and on the SCP1 monolayer. Adhesion rate, 
number of interactions steps and detachment force were lower for the 
antibody-treated PC3 cells in comparison to untreated PC3 cells on both 
substrates (Fig. 27, Fig. 28, Fig. 29). These results clearly revealed that cell-
to-cell interactions between PC3 and SCP1 are mediated also via β1 
integrins. However, we did not observe a difference between the adhesion of 
PC3 cells on SCP1 monolayers with and without collagenase treatment (Fig. 
28). The adhesion rate and number of steps were not significantly different 
between measurements of PC3 cells on SCP1 substrates with or without 
collagenase. Furthermore there was only a small difference (not significant) 
between detachment forces (Fig. 29B). Despite the fact that SCP1 cells 
express Col-I on their apical side (Fig. 24), we hypothesized that upon 
removal of Col-I from the apical surface, the adhesion of PC3 cells to SCP1 
monolayer should reduce. However it remained constant, collagenase 
treatment did not make any significant difference. This may be because the 
SCP1 monolayers were cultured for only two days, whereas deposition of an 
entire extracellular Col-I matrix in 2D monolayer cultures requires up to 3 
weeks according to Koellmer et al [117]. On the other hand, our observation 
also indicated that with the removal of Col-I from the apical side of the SCP1 
cells, additional adhesion molecules expressed by the SCP1 cells were 
exposed and could contribute to the interaction between PC3 and SCP1 cells. 
Another possibility to explain our data is that the treatment with the 
collagenase enzyme might not have effectively removed Col-I from the apical 
side of the SCP1 cells due to the protective effect of polysaccharides in the 
glycocalix of the SCP1 cells. Michigami et al. reported that cell-to-cell contact 
between bone marrow stromal and myeloma cells can also be established via 
VCAM-1 binding to α4β1-integrin [119]. Another study showed that co-
cultured PC3 and bone marrow stromal cells regulate their cell adhesion via 
α1, and α2 integrin subunits and VCAM-1[68]. Furthermore, both VCAM-1 and 
α4 integrin subunits are highly expressed in bone marrow derived MSCs and 
PC3, respectively [119,120]. Therefore, we propose that in addition to Col-I, 
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VCAM-1 might be an important partner for mediating the adhesive interactions 
between prostate cancer cells and bone marrow MSCs. However, to further 
rule out the involvement of VCAM-1 follow up studies have to be carried out. 
 
Cytoskeleton anchored membrane receptors were involved in the 
interactions of PC3 cells to Col-I and MSCs 
In addition to the adhesion, rate the average number of steps and the 
detachment force, we have also analyzed the force loading rates (slope of the 
force distance trace) prior to each step as a function of the step position: A 
horizontal plateau preceding a force step, is characteristic for a tether being 
pulled out of the cell membrane [106,109,110]. Here, the constant force prior 
to the unbinding event is caused by the constant tension of the plasma 
membrane [121].  However an increasing force just before the step (denoted 
as jump) is characteristic for the rupturing of a transmembrane-receptor, 
which is firmly connected to the cytoskeleton on its intracellular side 
[107,108].  
As shown in Fig. 20, we have counted the numbers of jump steps (F-step) 
and tethers (T-steps) and compare between PC3 and LNCaP. The results 
showed that in the case of PC3 cells, more than 50% of all detected steps 
exhibited filopodia and less than 40% exhibited the typical signature of 
tethers. For LNCaP cells, on the other hand, less than 40% of the steps 
appeared as filopodia steps and about 45% as tether-like steps. Important to 
note, this type of calculation has limits, since we had to remove steps and 
also slopes of positions shorter than 1 μm, and which we were not able to 
clearly distinguish too close at the border line (at slope = -10 pN/μm). 
Therefore, we added the parameter of step positions to the plots to make a 
clear distinction and drew 2D maps of the data (step positions vs slope). 
Hence, we could use the whole data sets without removing any shorter 
position steps or the steps close to the border line. The density distribution 
images of the force loading rate (slope) versus the step position shown in 
figures 31, 32, 33 and 34 revealed differences in the degree of cytoskeleton 
connection beneath the cell surface receptors involved in cell-cell and cell-
substrate interaction. For PC3 cells on Col-I substrate, after collagenase or 
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antibody treatment, the receptors were less connected to the cytoskeleton 
than in the case of untreated PC3 cells and Col-I substrates (Fig. 31B, 32B 
and 33B). For PC3 cells on SCP1 substrates, collagenase treatment did not 
change much the distribution of steps but moved the peak to higher step 
positions (Fig. 32A). This we concluded may be the effect by the removal of 
the tiny Col-I layer from SCP1 monolayers; thus, the cells could form easier 
and longer cell - cell attachment sites with their exposed membrane 
protrusions than in the previous case. Application of β1 blocking antibody to 
PC3 cells decreased the number of interactions between two cell types (Fig. 
28), but the distribution of steps was not much affected, and showed only 
broadened peak at the same position (Fig. 33A). However, these 
observations for PC3 - SCP1 interactions also suggested that different 
surface receptors can be involved depending on whether 1 integrins were 
blocked by an antibody or accessible Col-I was removed by collagenase 
treatment. This may also reflect the fact that, depending on their state, the 
involved integrin receptors can form or dissolve bonds to the actin 
cytoskeleton [105,122].  On Col-I substrate application of β1 blocking antibody 
to PC3 cells cause appearance of two tether peaks (Fig. 33B). This showed 
effective blocking of interactions between β1 integrins and Col-I. 
Taken together with the establishment of this new presentation method of the 
single cell force spectroscopy data, dynamics of the cell adhesion could be 
tested and for the first time the plots thus visualize details of the anchoring of 
bonds to the cell and provide a better understanding of the specificity of the 
receptor-ligand interactions.  
 
Cell membrane protrusions, such as filopodia actively took part in the 
interactions of PC cells to bone marrow constituents 
Cell migration is essential not only for tissue infiltration and the formation of 
metastases, but also for non-pathological processes, such as angiogenesis 
and leukocyte extravasation. In order to migrate, a cell has to pass through a 
sequence of distinct processes. Migration is initiated by cell polarization and 
the formation of membrane protrusions at the leading edge. Integrins fix 
cellular protrusions to the ECM, interact with the actin cytoskeleton, and 
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trigger the association of many different signaling molecules at the so-called 
focal contacts [123]. Filopodia are thin, actin-rich plasma-membrane 
protrusions that function as antennae for cells to probe their environment. 
Consequently, filopodia have an important role in cell migration. The initiation 
and elongation of filopodia depend on the precisely regulated polymerization, 
convergence and crosslinking of actin filaments [124]. Our observation that 
PC3 cells exhibited much more jump and filopodia steps which are formed by 
cytoskeleton-connected membrane proteins at the extended positions than 
LNCaP cells (Fig. 16, Fig. 17 and density plots in Fig. 31 to Fig. 36) may 
reflect the fact that PC3 cells tend to actively extrude filopodia when they 
come into contact with Col-I or SCP1 cells, while LNCaP cells form membrane 
tethers as they are not connected to the cytoskeleton. This novel observation 
is consistent with high resolution AFM and fluorescence microscopy studies 
[57], which showed that on Col-I-coated substrates, PC3 cells exhibit a large 
number of well pronounced filopodia, while LNCaP cells on Col-I coated 
substrates remain smooth and show almost no filopodia. Taken together, 
these findings suggest a role for filopodias in promoting cell adhesion to ECM 
proteins and to surrounding neighbor cells in PC metastasis and this adhesion 
may have a major role in migration of PC cells in bone tissue. 
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6.     Conclusions and outlook 
 
PC metastasis into bone tissue is still a major problem that should be deeply 
investigated to define the mechanism of invasion. Several aspects of PC 
metastasis into bone have been enlightened, but there are still some gaps in 
our understanding of this process. Col-I and MSCs are important components 
of the bone marrow environment and seem to play distinct roles in the PC 
invasion of bone. However, the exact interaction mechanisms of PC cells with 
these bone marrow components still needs to be elucidated and the 
responsible cell adhesion molecules to be identified. This necessity led us to 
investigate in a great detail the PC cell adhesion mechanism to Col-I and 
mesenchymal stem cells (MSCs). Following our extensive analyses we 
concluded: 
 
1. When co-cultured with the SCP1 cells, PC3 cells showed enhanced 
adhesion, spreading and proliferation rate. Furthermore, we have found 
that prostate cancer cells derived from bone metastasis (PC3) have a 
higher affinity to MSCs (SCP1 cell line) as well as to the extra cellular 
bone matrix protein collagen type I (Col-I), than lymph-derived prostate 
cancer cells (LNCaP).  
2. Col-I-binding integrins α1β1 and α2β1 integrins were expressed at higher 
levels on PC3 cells than LNCaP cells. Among the two different 
combinations α2β1 receptor was the dominant one in PC3. PC3 cell 
adhesion to Col-I substrates was mediated via this integrin. 
3. On Col-I substrate and on SCP1 monolayer, PC3 cells formed 
significantly more frequent interactions and stronger adhesion forces than 
LNCaP cells. 
4. Blocking of β1 integrin caused a clear reduction in the adhesion of PC3 
cells to Col-I and SCP1. Cell-to-cell interactions between PC3 cells and 
SCP1 cells appeared to be also mediated by β1 integrins. On the other 
hand proteolitic degradation of the extracellularly expressed Col-I on 
SCP1 monolayers did not change the adhesion regime of PC3 cells. 
These results suggest that in addition to Col-I, other potent ligands for β1 
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integrins are expressed by MSCs and may play a role in facilitating PC3-
MSC interactions.  
5. We have shown that deriving and generating slope-position density-plots 
from force spectroscopy data is a veyr novel and useful method to 
visualize the embedding and anchorage of adhesion molecules in the cell. 
These plots reflect the substrate-dependent complex adhesion behavior 
of the cells. With the results of these analyses, we concluded that PC3 
cells use cytoskeleton-connected membrane receptors to generate 
specific de-adhesion forces during interaction with bone marrow-derived 
substrates (Col-I and MSCs). Moreover, our new data may reflect the fact 
that PC3 cells tend to actively extrude filopodia when they come into 
contact with Col-I or SCP1 cells, while LNCaP cells form membrane 
tethers as they are not connected to cytoskeleton. These findings, to our 
knowledge, are for the first time reported. 
 
Biophysical characterization of PC cell interaction to bone marrow 
components will help researchers tremendously in understanding the nature 
of PC bone metastasis. Our study has demonstrated remarkable effect of β1 
integrins in the adhesion of PC3 cells to MSCs. In addition, we have found 
that extracellularly secreted Col-I is not the only partner for these integrins in 
PC3-MSC interaction. Next, we have defined a novel method to discriminate 
the adhesion steps in force spectroscopy of cells, which is based on the 
anchorage of membrane receptors to cytoskeleton elements. With the help of 
these analyses we concluded that PC3 cells could use cytoskeleton-
connected membrane-anchored receptors and seem to utilize their filopodia to 
establish these adhesive bonds. Together with the present study, follow up 
investigations could help to shed more light on the membrane molecular 
partner of β1 that is expressed on the MSCs and governs PC3-MSC 
interaction. Cumulatively, we believe that reaching a complete understanding 
of the mechanism of action of prostate cancer cells could be used to design 
and generate very specific therapeutic agents or strategies that powerfully 
block the metastatic behavior of certain prostate cancer cells towards bone 
tissue. 
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The results presented in the sections 4.1 to 4.5 are already published in the 
research article entitled “Probing the Interaction Forces of Prostate Cancer 
Cells with Collagen I and Bone Marrow-Derived Stem Cells on the Single Cell 
Level” by Sariisik et al., Plos One, in 2013 [101].  
Some of the results presented in sections 4.7 and 4.8 are also used in the 
research article entitled “Decoding Cytoskeleton-Anchored and Non-Anchored 
Receptors from Single-Cell Adhesion Force Data”, by Sariisik et al., 
Biophysical Journal, in 2015 [125]. 
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7. Summary 
 
Prostate cancer is one of the most commonly diagnosed cancer in males. At 
the early stages of cancer surgical and hormonal therapies can be useful 
applied. The principal problem arising from prostate cancer is its 
predisposition to metastasize. After some point they form hormone 
independent cells, which can also be highly invasive. This tendency arises 
from specific molecular mechanisms and interactions that together lead to 
metastatic invasion into bone. 
In order to investigate in detail on this topic, typical components of bone tissue 
were presented as substrates for two species of prostate carcinoma cell lines 
(PC3 and LNCaP). This study was conducted with a variety of complementary 
techniques to investigate cell adhesion. While PC3 cells turned out to instantly 
interact strongly with bone tissue, LNCaP cells interacted weak and in 
contrast to PC3 even refused proliferating in this environment. By quantitative 
PCR and real time PCR, β1-integrins were identified as key players for the 
interaction between PC3 cells and bone tissue. Therefore, a prostate cell 
immobilized to the force sensor was mechanically brought in a controlled 
short contact to a collagen type–I (Col-I) substrate or to a monolayer of a 
bone marrow derived mesenchymal stem cell line (SCP1). Then the cell was 
retracted while recording interaction forces. An antibody specifically blocking 
β1-integrins corroborated the hypothesis that β1-integrins play a major role in 
this interaction, but also showed that due to a high integrin turnover rate 
antibody treatment might not be the ultimate strategy to interfere with prostate 
carcinoma metastasis into the bone marrow. Similar findings characterized a 
treatment of SCP1 monolayers with collagenase. 
Even though all measured parameters resulting from the force measurements 
revealed an almost identical behavior of the PC3 cells probed on both 
surfaces Col-I and SCP1, the treatment with collagenase suggested the 
possibility of PC3 cells involving different mechanisms for the interaction to 
Col-I or to SCP1 respectively. 
Long-term assays up to days for PC3 and LNCaP adhesion, proliferation and 
spreading in co-culture with SCP1 uncovered a very similar picture for the cell 
interactions as the force measurements. 
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AFM, furthermore, provided a direct measure of the cell elasticity (Youngs’ 
modulus) and showed PC3 cells to be mechanically three times stiffer than 
LNCaP cells. 
Last during this project, a new evaluation method for force measurements 
was developed, that allowed to conclude on the connection of the adhesion 
molecules (integrins) to the intracellular cytoskeleton. From loading-rate vs. 
position probability density plots the anchorage of each individual detected 
unbinding event could be classified as rather membrane bound (tether) or 
cytoskeleton bound (jump). This method was clearly verified by treating the 
cells with Latrunculin-A a destructor of the actin filaments. For the interaction 
of prostate cell lines with bone tissue this evaluation method revealed not only 
that PC3 cells rather utilize cytoskeleton-supported receptors (filopodia) in 
contrast to LNCaP cells utilizing membrane bound receptors (tether) but also 
how blocking antibody treatment removed cytoskeleton-anchored receptors 
from participating in adhesion.  
Taken together, these findings might open a window for new applications to 
interfere with prostate carcinoma metastasis at the intracellular side of 
adhesion receptors by preventing cytoskeleton anchorage. 
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8. Zusammenfassung 
 
Zu den am häufigsten in männlichen Patienten diagnostizierten Krebsarten 
gehört Prostatkrebs. Im Anfangsstadium können Resektion und 
Hormontherapie mit Erfolg eingesetzt werden. Aus seiner Neigung zur 
Metastasierung erwächst allerdings ein grundlegendes Problem, denn ab 
einem bestimmten Stadium werden die Zellen hormonresistent und können 
dann auch sehr invasiv werden. Diese Eigenschaft rührt von bestimmten 
molekularen Mechanismen und Wechselwirkungen, die in Kombination zu 
metastatischem Eindringen in das Knochengewebe führen. 
Um diese Zusammenhänge genauer zu verstehen wurden zwei Arten von 
Prostatakrebszellinien (PC3 und LNCap) typische Bestandteile des 
Knochengewebes präsentiert. In dieser Studie kamen unterschiedliche 
komplementäre Techniken zur Untersuchung der Zelladhäsion zum Einsatz. 
Dabei wechselwirkten PC3 Zellen sofort und sehr stark mit Knochengewebe, 
während die LNCaP Zellen schwach wechselwirkten und im Gegensatz zu 
PC3 Zellen sich in diesem Milieu nicht teilten. Mittels Quantitativer PCR und 
Echtzeit PCR wurden die β1-Integrine als die Hauptverantwortlichen für die 
Wechselwirkung zwischen PC3 Zellen und dem Knochengewebe identifiziert. 
Mittels Kraftmikroskopie (AFM) wurden die Kräfte zwischen den Prostata 
Zelllinien und dem Knochengewebe direkt gemessen. Hierfür wurde eine am 
Kraftsensor immobilisierte Prostata Krebszelle kontrolliert für einen kurzen 
Moment mechanisch in Kontakt mit einem Kollagen Typ-I (Col-I) Substrat 
oder mit einem Zellmonolayer einer mesenchymen Stammzellline aus dem 
Knochenmark (SCP1) gebracht. Die Wechselwirkungskräfte wurden 
aufgezeichnet, während die Zelle wieder vom Substrat getrennt wurde. Ein 
β1-Integrin blockender Antikörper bestätigte noch einmal die Hypothese, dass 
β1-Integrine für diese Wechselwirkung die wesentliche Rolle spielen. Aber es 
zeigte sich auch, dass eine Behandlung gegen Metastasierung von Prostata 
Karzinomen in das Knochenmark mit diesem Antikörper wegen des hohen 
Integrin Durchsatzes nicht die beste Strategie sein kann. Ähnliche Ergebnisse 
erzielte die Behandlung mit von SCP1 Monolayern mit Kollagenase. 
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Obwohl alle Parameter aus den Kraftmessungen darauf hin deuteten, dass 
die PC3 Zellen sich nahezu identisch sowohl auf Col-I als auch auf SCP1 
verhielten, legte der Einsatz von Kollagenase nahe, dass PC3 Zellen 
möglicherweise verschiedene Mechanismen für die Wechselwirkung mit Col-I 
oder SCP1 verwenden.  
Langzeit Testreihen von bis zu einigen Tagen zur Adhäsion, zur Zellteilung 
und zur Ausbreitung von PC3 und LNCaP Zellen in Mischkultur mit SCP1 
Zellen zeichneten ein sehr ähnliches Bild der zellulären Wechselwirkungen 
wie die Kraftmessungen.  
Zusätzlich bietet das AFM die direkte Bestimmung der Zellelastizität (Youngs’ 
Modul) und es zeigte sich, dass PC3 Zellen mechanisch dreimal steifer sind 
als die LNCaP Zellen. 
Insbesondere wurde im Rahmen dieses Projektes eine neue 
Auswertungsmethode entwickelt, die Rückschlüsse über die Verankerung der 
Adhäsionsmolleküle (Integrine) mit dem intrazellulären Zytoskelett erlaubt. 
Durch Auftragung der Wahrscheinlichkeitsdichte der Ladungsrate gegen die 
Position konnte die Verankerung jedes einzelnen detektierten 
Bindungsereignisses in eher membrangebunden (Tether) oder 
Zytoskelettverbunden (Jump) unterteilt werden. Durch die Behandlung der 
Zellen mit dem Aktinfilament zersetzenden Latrunkulin-A konnte diese 
Methode eindeutig bestätigt werden. In Bezug auf die Wechselwirkung der 
Prostata Zelllinien mit Knochengewebe konnte diese 
Auswertungsmethodenicht nur zeigen, dass PC3 Zellen eher 
zytoskelettgebundene Rezeptoren (Filpodien) verwenden, während LNCaP 
Zellen eher membrangebundene Rezeptoren (Tether) verwenden, sondern 
sie zeigte auch, dass der Einsatz des blockenden Antikörpers 
zytoskelettgebundenene Rezeptoren daran hinderte an der Adhäsion mit zu 
wirken.  
Diese Ergebnisse könnten eine Tür zu neuen Anwendungen gegen 
Metastasierung von Prostata Krebs an der Intrazellulären Seite der 
Rezeptoren öffnen wobei deren Verankerung mit dem Zytoskelett 
unterbunden wird.  
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Single cell force spectroscopy 
Transforming growth factor beta 
Vascular cell adhesion molecule -1 
Vascular endothelial growth factor 
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